Veronique
Veronique Arnoult Delest, Antony FR
Patent application number | Description | Published |
---|---|---|
20080199567 | Fresh Dairy Products with Satietogenic Power and Methods for Preparing Same - The invention concerns a fresh dairy product with low fat and sugar content and low energy density, comprising one or several satietogenic ingredients, as well as a method for making such a product. Said satietogenic ingredient(s) comprise proteins, in particular milk proteins and preferably serum milk proteins, associated with water-soluble dietary fibers and preferably viscosifying water-soluble dietary fibers. | 08-21-2008 |
20090130258 | Fresh Dairy Products With Satietogenic Power Based on Water-Soluble Fibers and Methods for Preparing Same - The invention concerns a fresh dairy product with low fat and sugar content and low energy density, comprising one or several satietogenic ingredients, as well as a method for making such a product. Said satietogenic ingredient(s) comprise viscosifying water-soluble dietary fibers among which at least one guar gum at least partly hydrolyzed. | 05-21-2009 |
Veronique Barberousse, Hauteville-Les-Dijon FR
Patent application number | Description | Published |
---|---|---|
20080293768 | Novel Compounds Derived From 5-Thioxylose And Their Use In Therapeutics - The invention relates to novel 5-thioxylose compounds, preferably derivatives of the 5-thioxylopyranose type, to the process for their preparation and to their use as active principles of drugs intended especially for the treatment or prevention of thrombosis or cardiac insufficiency. | 11-27-2008 |
20090118325 | 5-Thioxylopyranose Compounds - 5-thioxylose compounds, especially 5-thioxylopyranose compounds, a process for their preparation, and their use for treating and/or inhibiting thromboses, especially venous thromboses. The compounds correspond to formula I: | 05-07-2009 |
20090182013 | Derivatives of 5-Thioxylopyranose and Use of Same for Treatment - The invention relates to new compounds of 5-thioxilose, preferably derivatives of the 5-thioxilopyranose type, and to a method for preparing the same and their use as the active ingredient of drugs mainly intended for treating or inhibiting thrombosis or heart failure or thromboembolic diseases. | 07-16-2009 |
20090186840 | 5-Thioxylopyranose Compounds - Compounds of 5-thioxylopyranose, preferably derivatives of the 5-thioxilopyranose type, a method for preparing such compounds, and the use of such compounds as an active ingredient in pharmaceutical compositions which are useful, in particular, for treating or inhibiting thrombosis or heart failure or thromboembolic disease states. | 07-23-2009 |
Veronique Barlet-Gouedard, Chatenay Malabry FR
Patent application number | Description | Published |
---|---|---|
20090126930 | Cement Composition for Carbon Dioxide Supercritical Environment - The invention provides a cement composition resistant to carbon dioxide including a hollow element for trapping carbonation products. The hollow element can be an additional component added to the cement composition, this component is made of hollow spherical or quasi spherical particles as cenospheres, sodium-calcium-borosilicate glass, silica-alumina microspheres, or a combination thereof. Or the hollow element is a spherical or quasi spherical void made in the set cement, for example by foaming the cement composition with a gas as air, nitrogen or a combination thereof. Use of such cement composition in carbon dioxide application is disclosed. Additionally, a method to cement a part of a borehole in presence with carbon dioxide is disclosed, a method to repair a part of a borehole in presence with carbon dioxide is disclosed using the above cement composition and a method to plug a part of a borehole in presence with carbon dioxide is disclosed. | 05-21-2009 |
20120206144 | Method and Apparatus for Monitoring Cement Sheath Degradation Related to CO2 Exposure - The present invention provides methods, apparatuses and systems for more effectively and efficiently, directly and indirectly monitoring cement degradation related to carbon dioxide exposure by measuring one or more electrical properties related to resistivity of cement behind a casing in a well. | 08-16-2012 |
Veronique Blanchard-Bregeon, Paris FR
Patent application number | Description | Published |
---|---|---|
20110059092 | ANTIBODIES SPECIFIC OF THE BETA-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS - The present invention relates to a monoclonal antibody which specifically binds to the N-terminal region of Aβ | 03-10-2011 |
20150031893 | AN H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE - This disclosure relates to methods of using 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide in a disease modifying therapy of Alzheimer's disease, other tauopathies and related neurodegenerative diseases. | 01-29-2015 |
Veronique Bonnelye, Conflans Sainte Honorine FR
Patent application number | Description | Published |
---|---|---|
20090211974 | WATER CLARIFYING APPARATUS AND IMPLEMENTING METHOD - The invention concerns a water clarifying device comprising a flotation zone (c), a membrane-based filtering zone (e) and extracting means (d), the flotation zone (c) and the membrane-based filtering zone (e) having a common partition wall (P), the common partition wall (P) including in its lower part an opening (o) directly allowing through flotated water towards the filtering zone (e), thereby feeding the membranes with flotated water from down upwards both in filtering phase and in backwashing phase. | 08-27-2009 |
Veronique Bordas, Antony FR
Patent application number | Description | Published |
---|---|---|
20080274059 | MITE FUSION PROTEINS - The present invention relates to fusion proteins comprising a Group I allergen and a Group II allergen from the genus | 11-06-2008 |
Veronique Bossennec, Serezin De Rhone FR
Patent application number | Description | Published |
---|---|---|
20110160407 | NOVEL POLYAMIDEIMIDES AND PREPARATION AND COMPOSITIONS COMPRISED THEREOF - Novel semi-aromatic polyamideimides are prepared by melt polymerization of at least one organic compound having carboxyl groups, of at least one diamine compound and, optionally, of at least one diacid compound; such novel polyamideimides are formulated into compositions based on a thermoplastic matrix. | 06-30-2011 |
Veronique Bouchain, Paris FR
Patent application number | Description | Published |
---|---|---|
20080196322 | Shiftable Building - The invention concerns a building ( | 08-21-2008 |
Veronique Boudolf, Gent BE
Patent application number | Description | Published |
---|---|---|
20080207449 | Nucleic Acid Molecules Encoding Plant Cell Cycle Proteins and Uses Therefor - The invention provides isolated nucleic acids molecules, designated CCP nucleic acid molecules, which encode novel cell cycle associated polypeptides. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CCP, nucleic acid molecules, host cells into which the expression vectors have been introduced, and transgenic plants in which a CCP gene has been introduced or disrupted. The invention still further provides isolated CCP proteins, fusion proteins, antigenic peptides and anti-CCP antibodies. Agricultural, diagnostic, screening, and therapeutic methods utilizing compositions or the invention are also provided. | 08-28-2008 |
20120216320 | METHOD FOR MODULATING PLANT GROWTH, NUCLEIC ACID MOLECULES AND POLYPEPTIDES ENCODED THEREOF USEFUL AS MODULATING AGENT - The invention provides isolated nucleic acids molecules, designated CCP nucleic acid molecules, which encode novel cell cycle associated polypeptides. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CCP nucleic acid molecules, host cells into which the expression vectors have been introduced, and transgenic plants in which a CCP gene has been introduced or disrupted. The invention still further provides isolated CCP proteins, fusion proteins, antigenic peptides and anti-CCP antibodies. Agricultural, diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided. | 08-23-2012 |
Veronique Buclin, Morlon CH
Patent application number | Description | Published |
---|---|---|
20080271264 | Indolylthiazoliumazo Dyes-Containing Colorants for Keratin Fibers - The present invention has for an object agents for coloring keratin fibers and containing at least one indolylthiazoliumazo dye of general formula (I) | 11-06-2008 |
Veronique Cammas, Kiel DE
Patent application number | Description | Published |
---|---|---|
20120017550 | Horse Rug and Safety Closure for Horse Rugs - A horse rug comprising at least one closure, wherein the closure is made of a first closure element fastened to the horse rug at a first position, a second closure element fastened to the horse rug at a second position, and a third closure element connecting the first closure element to the second closure element, wherein the third closure element has a lower tear resistance than the first and second closure elements. | 01-26-2012 |
Veronique Capdevielle, Magny Les Hameaux FR
Patent application number | Description | Published |
---|---|---|
20120008593 | METHOD FOR PRIORITIZING HANDOVER TARGETS FOR SCANNING BY A MOBILE TERMINAL IN A WIRELESS NETWORK - A method for prioritizing handover targets for scanning by a mobile terminal, MS ( | 01-12-2012 |
20140099962 | CELL PARTITIONING FOR HIGH-SPEED USERS - The present invention relates to a radio access arrangement for operating a radio cell (C), and comprising at least one wireless transceiver ( | 04-10-2014 |
Veronique Capdevielle, Nozay FR
Patent application number | Description | Published |
---|---|---|
20110170518 | MULTI-MODE TRAFFIC ENGINEERED HANDOVER MANAGEMENT DEVICE AND METHOD FOR A BROADBAND WIRELESS ACCESS NETWORK - A handover management device (D | 07-14-2011 |
20120244873 | ADAPTIVE TRAFFIC AND INTERFERENCE AWARE RADIO RESOURCE MANAGEMENT - A method for radio resources management within a set of cells (C | 09-27-2012 |
Veronique Cerpentier, Loksbergen BE
Patent application number | Description | Published |
---|---|---|
20110257403 | Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of HCV - The present invention relates to the cinchonidine salt | 10-20-2011 |
20150080577 | Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of HCV - The present invention relates to the cinchonidine salt | 03-19-2015 |
Veronique Cossin, Beauvais FR
Patent application number | Description | Published |
---|---|---|
20080226771 | ICED CONFECTIONERY ARTICLE AND PROCESS FOR PREPARING IT - An iced confectionery article, which is in particular a molded iced confectionery article based on water ice with a soft-core texture. This article includes i) a core of water ice containing 20 to 40% by weight of solids, having a degree of overrun of 20 to 80% and a texture which is similar to that of an extruded ice-cream, which contains, where appropriate, pieces, and ii) a shell of water ice with no overrun, containing 20 to 35% by weight of solids. In another embodiment, the core contains inclusions ranging in size from 1 to 10 mm. The invention also relates to processes for preparing these molded iced confectionery articles. | 09-18-2008 |
Veronique Coxam, Ceyrat FR
Patent application number | Description | Published |
---|---|---|
20120135957 | COMPOSITIONS CONTAINING MIXTURES OF FERMENTABLE FIBERS - The present invention relates to synergistic compositions comprising mixtures of fermentable fibers. The present invention specifically relates to composition comprising inulin and arabinoxylan for use in reducing, preventing and/or treating inflammation, wherein said arabinoxylan is partially hydrolyzed arabinoxylan and wherein the ratio of said inulin to said arabinoxylan and/or partially hydrolyzed arabinoxylan is between 65%/35% by weight and 90%/10% by weight. | 05-31-2012 |
Veronique Crocq, Paris FR
Patent application number | Description | Published |
---|---|---|
20110245486 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES - The invention relates to a method for producing 1,4-benzothiepin-1,1-dioxide derivatives substituted with benzyl groups. | 10-06-2011 |
Veronique Crocq-Stuerga, Dijon FR
Patent application number | Description | Published |
---|---|---|
20100160670 | NOVEL PROCESS FOR THE PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM HEXANOIC ACID ESTERS AND INTERMEDIATES USED IN THE SYNTHESIS OF CHIRAL-2-(BROMOMETHYL)-2-ETHYLHEXANOIC ACID - The present invention comprises a novel process for the preparation of a chiral compound of formula (I) | 06-24-2010 |
Veronique Damagnez, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20110065898 | Immunosuppressant Target Proteins - The present invention relates to the discovery of novel proteins of mammalian origin which are immediate downstream targets for FKBP/rapamycin complexes. | 03-17-2011 |
Veronique De Brabandere, Gent BE
Patent application number | Description | Published |
---|---|---|
20120141460 | METHOD FOR THE PRODUCTION OF VARIABLE DOMAINS - The present invention provides methods for the expression and/or production of variable domains with a C-terminal extension that can be used for coupling of the variable domain to one or more further groups, residues or moieties. In the method of the invention a yield of at least 80% of variable domains with a cysteine containing C-terminal extension is obtained. Also variable domains are provided and polypeptides comprising one or more variable domains obtainable by the methods of the present invention, as well as compounds that comprise such variable domains and/or polypeptides coupled to one or more groups, residues or moieties. | 06-07-2012 |
20120244158 | STABLE FORMULATIONS OF POLYPEPTIDES AND USES THEREOF - Formulations are provided that contain single variable domains with a good solubility and good stability under different storage, transportation and stress conditions. The formulations are useful as pharmaceutical formulation. The formulation comprises an aqueous carrier with a pH of 5.5 to 8.0, a buffer selected from the group consisting of histidine pH 6.0-6.5, hepes pH 7.0-8.0, MES pH 6.0, succinate pH 6.0-6.5 and acetate pH 5.5-6.0; an excipient; and/or a surfactant selected from Tween 80, Tween 20 and poloxamers. The formulation is further characterized that it has an inorganic salt concentration of 150 mM or lower. The invention further relates to containers and pharmaceutical units comprising such formuSations and to methods for preparing and prophylactic and therapeutic uses of the formulations and pharmaceutical units of the invention. | 09-27-2012 |
20120264917 | BIPARATOPIC PROTEIN CONSTRUCTS DIRECTED AGAINST IL-23 - Biparatopic protein constructs that are directed against IL-23, and in particular against the p19 subunit of IL-23. The constructs comprise at least a first binding domain or binding unit directed against a first defined epitope on p19 and at least a second binding domain or binding unit directed against a second defined epitope on p19 (or the p19/p40 interface). The binding domains or binding units may in particular be a domain antibody, a single domain antibody, a dAb or a Nanobody®. The constructs and pharmaceutical compositions comprising the same can be used for the prevention and/or treatment of diseases and disorders associated with IL-23 or IL-23 mediated signaling, such as inflammation and inflammatory disorders such as colitis, Crohn's disease and IBD, infectious diseases, psoriasis, cancer, autoimmune diseases, sarcoidosis, transplant rejection, cystic Fibrosis, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, viral infection, and common variable immunodeficiency. | 10-18-2012 |
20130109842 | AMINO ACID SEQUENCES OF NANOBODIES DIRECTED AGAINST P19 SUBUNIT OF THE HETERODIMERIC CYTOKINE IL-23 | 05-02-2013 |
20140178383 | STABLE FORMULATIONS OF POLYPEPTIDES AND USES THEREOF - Formulations are provided that contain single variable domains with a good solubility and good stability under different storage, transportation and stress conditions. The formulations are useful as pharmaceutical formulation. The formulation comprises an aqueous carrier with a pH of 5.5 to 8.0, a buffer selected from the group consisting of histidine pH 6.0-6.5, hepes pH 7.0-8.0, MES pH 6.0, succinate pH 6.0-6.5 and acetate pH 5.5-6.0; an excipient; and/or a surfactant selected from Tween 80, Tween 20 and poloxamers. The formulation is further characterized that it has an inorganic salt concentration of 150 mM or lower. | 06-26-2014 |
20150023963 | METHOD FOR THE PRODUCTION OF VARIABLE DOMAINS - The present invention provides methods for the expression and/or production of variable domains with a C-terminal extension that can be used for coupling of the variable domain to one or more further groups, residues or moieties. In the method of the invention a yield of at least 80% of variable domains with a cysteine containing C-terminal extension is obtained. Also variable domains are provided and polypeptides comprising one or more variable domains obtainable by the methods of the present invention, as well as compounds that comprise such variable domains and/or polypeptides coupled to one or more groups, residues or moieties. | 01-22-2015 |
Veronique De-Jonghe, La Terrasse FR
Patent application number | Description | Published |
---|---|---|
20090114970 | EMBEDDED DRAM WITH INCREASED CAPACITANCE AND METHOD OF MANUFACTURING SAME - An embedded DRAM memory device comprising one or more cylinder type cell capacitors. Contact pillars ( | 05-07-2009 |
Veronique Delcenserie, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20080274085 | Probiotic Bifidobacterial Species - A probiotic composition comprising a | 11-06-2008 |
20110262400 | PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH - This invention provides isolated and characterized secreted molecules from probiotic bacteria for use in compositions and methods for the treatment and/or prevention of infection by harmful pathogenic bacteria. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal. | 10-27-2011 |
Veronique Delest, Antony FR
Patent application number | Description | Published |
---|---|---|
20100112635 | Protein hydrolysates enriched in peptides having a carboxy terminal proline residue - A method of enzymatically producing a protein hydrolysate from a protein substrate is described, wherein a proline-specific endoprotease or a composition containing a proline-specific endoprotease and optionally a subtilisin or a metallo endoprotease, and other enzymes such as carboxypeptidases, is used to produce a protein hydrolysate enriched in peptide fragments having a carboxy-terminal proline residue. Such protein hydrolysates may be used as such or to reduce bitterness in foods nutritionally supplemented by protein hydrolysates, as well as to produce hydrolysate-containing foodstuffs having low antigenicity. | 05-06-2010 |
Veronique Deparis, Clarens CH
Patent application number | Description | Published |
---|---|---|
20090124006 | Serum-Free Culture Medium for the Production of Recombinant Gonadotropins - The present invention is in the field of the manufacture of recombinant proteins. More specifically, it relates to the use of a serum-free culture medium comprising an antioxidant for the production of recombinant dimeric gonadotropins. The antioxidant may be selected from the group consisting of L-glutathione, 2-mercaptoethanol, L-methionine and a combination of ascorbic acid and of (+)-alpha-tocoplierol. | 05-14-2009 |
Veronique Detappe, Fribourg CH
Patent application number | Description | Published |
---|---|---|
20080227716 | Use of Peptides for Protecting Skin from Hair-Treatment Agents - The present invention relates to the use of short-chain peptides for the protection of the skin from hair-treatment agents, and particularly for the protection of the scalp from dyes or colorants. | 09-18-2008 |
Veronique Ferger Born Picard, Sceaux FR
Patent application number | Description | Published |
---|---|---|
20100298224 | USE OF MUTATED ANTITHROMBINS FOR TREATING OR PREVENTING COAGULATION DISORDERS - Use of a mutated antithrombin having substantially no activity, in particular no anticoagulant activity, possibly in association with an anticoagulant, for the preparation of a drug intended for the prevention or treatment of pathologies linked to or associated with coagulation disorders. | 11-25-2010 |
20120088715 | MUTATED ANTITHROMBINS, A PROCESS FOR PREPARING THE SAME AND THEIR USE AS DRUGS - The present invention relates to the use of a composition including of at least a mutated antithrombin | 04-12-2012 |
Veronique Garat, Caluire FR
Patent application number | Description | Published |
---|---|---|
20100116383 | METHOD OF HEAT TREATMENT FOR DESENSITIZING A NIKEL-BASED ALLOY RELATIVE TO ENVIRONMENTALLY-ASSISTED CRAKING, IN PARTICULAR FOR A NUCLEAR FOR A NUCLEAR REACTOR FUEL ASSEMBLY AND FOR A NUCLEAR REACTOR, AND A PART MADE OF THE ALLOY AND SUBJECTED TO THE TREATMENT - A heat treatment method for desensitizing a nickel-based alloy with respect to environmentally-assisted cracking, the alloy having the following composition in percentages by weight: C≦0.10%; Mn≦0.5%; Si≦0.5%; P≦0.015%; S≦0.015%; Ni≧40%; Cr=12%-40%; Co≦10%; Al≦5%; Mo=0.1%-15%; Ti≦5%; B≦0.01%; Cu≦5%; W=0.1%-15%; Nb=0-10%; Ta≦10%; the balance being Fe, and inevitable impurities that result from processing, characterized in that the alloy is held at 950° C.-1160° C. in an atmosphere of pure hydrogen or containing at least 100 ppm of hydrogen mixed with an inert gas. A part made of a nickel-based alloy having the composition and that has been subjected to the heat treatment. | 05-13-2010 |
Veronique Gomord, Rouen FR
Patent application number | Description | Published |
---|---|---|
20090312240 | Synthesis of Sialic Acid in Plants - A method of synthesizing sialic acid in plants, and plants capable of synthesizing sialic acid is provided. Furthermore, a method of producing sialylated a protein in a plant is also provided. The method to synthesize sialic acid comprises providing a plant comprising a nucleotide sequence encoding N-acetyl neuraminic acid (Neu5Ac) synthase or Neu5Ac lyase, and expressing the nucleotide sequence thereby synthesizing sialic acid. The plant may also co-express a nucleotide sequence encoding one or more than one of an epimerase, a CMP-Neu5 Ac synthase, CMP-Neu5Ac transporter and a sialyltransferase. | 12-17-2009 |
20110008837 | MODIFYING GLYCOPROTEIN PRODUCTION IN PLANS - A method for synthesizing a protein of interest with a modified N-glycosylation profile within a plant, a portion of a plant, or a plant cell is provided. The method comprises co-expressing within a plant a nucleotide sequence encoding a first nucleotide sequence encoding a hybrid protein (GNT1-GalT) comprising a CTS domain of N-acetylglucosaminyl transferase (GNT1) fused to a catalytic domain of beta-1,4galactosyltransferase (GalT), the first nucleotide sequence operatively linked with a first regulatory region that is active in the plant, and a second nucleotide sequence for encoding the protein of interest, the second nucleotide sequence operatively linked with a second regulatory region that is active in the plant. The first and second nucleotide sequences are co-expressed to synthesize a protein of interest comprising glycans with the modified N-glycosylation profile within the plant, the portion of the plant, or the plant cell. | 01-13-2011 |
Veronique Gossele, Gent BE
Patent application number | Description | Published |
---|---|---|
20090320154 | STRESS RESISTANT PLANTS - Stress tolerance in plants and plant cells is achieved by using nucleotide sequences encoding enzymes involved in the NAD salvage synthesis pathway and/or the NAD de novo synthesis pathway from fungal or yeast like organisms other than | 12-24-2009 |
20100180351 | NOVEL GENES ENCODING INSECTICIDAL PROTEINS - The present invention relates to novel DNA sequences encoding insecticidal Cry1 C proteins derived from | 07-15-2010 |
20110131672 | STRESS RESISTANT PLANTS - Stress tolerance in plants and plant cells is achieved by using nucleotide sequences encoding enzymes involved in the NAD salvage synthesis pathway and/or the NAD de novo synthesis pathway e.g. for overexpression in plants. | 06-02-2011 |
20120204292 | STRESS RESISTANT PLANTS - Stress tolerance in plants and plant cells is achieved by using nucleotide sequences encoding enzymes involved in the NAD salvage synthesis pathway and/or the NAD de novo synthesis pathway from fungal or yeast like organisms other than | 08-09-2012 |
20130283482 | STRESS RESISTANT PLANTS - Stress tolerance in plants and plant cells is achieved by using nucleotide sequences encoding enzymes involved in the NAD salvage synthesis pathway and/or the NAD de novo synthesis pathway from fungal or yeast like organisms other than | 10-24-2013 |
20140366216 | Stress Resistant Plants - Stress tolerance in plants and plant cells is achieved by using nucleotide sequences encoding enzymes involved in the NAD salvage synthesis pathway and/or the NAD de novo synthesis pathway e.g. for overexpression in plants. | 12-11-2014 |
Veronique Grillier-Lanoir, Besancon FR
Patent application number | Description | Published |
---|---|---|
20090165795 | METHOD AND APPARATUS FOR RESPIRATORY THERAPY - The disclosure provides a method for delivering pressurized gas to an airway of a subject. The disclosure also provides a system for delivering pressurized gas to an airway of a subject. The disclosure further provides a computer-readable storage medium containing a set of instructions executable on a processor that include routines to monitor a respiratory flow rate from a subject, generate a filtered flow and a dynamic flow from the respiratory flow rate, and control a gas generator connected to a breathing device. | 07-02-2009 |
20090241952 | SYSTEMS AND METHODS FOR COMPENSATING FOR PRESSURE DROP IN A BREATHING ASSISTANCE SYSTEM - A breathing assistance system configured to determine pressure drop may include a gas delivery system configured to deliver gas toward a patient, one or more sensors configured to measure one or more parameters of gas delivered by the gas delivery system, a calibration module, and a pressure drop calculation module. The calibration module may be configured to perform one or more pressure drop calibration tests, each pressure drop calibration test measuring a pressure drop in gas flowing through a breathing assistance system apparatus at a particular flow rate; and based at least on the results of the one or more pressure drop calibration tests, generating a non-linear equation relating (a) pressure drop in gas flowing through the breathing assistance system apparatus with (b) flow rate of gas flowing through the breathing assistance system apparatus. The pressure drop calculation module may be configured to determine pressure drops in gas flowing through the breathing assistance system apparatus for various flow rates based at least on the non-linear equation. | 10-01-2009 |
Veronique Hall-Goulle, Dornach DE
Patent application number | Description | Published |
---|---|---|
20100295287 | SECURITY ELEMENT - The present invention is in the field of security documents, more particularly in the field of security elements aimed to protect security documents against copying (illegal reproduction) and counterfeiting. It discloses a security element having a coating layer(s) which changes its visual appearance after irradiation with light, especially with UV light and reverts back to the original state within a few seconds. Security documents comprising said security element, as well as a method for producing said security element, are also disclosed. | 11-25-2010 |
Veronique Henderickx, Rixensart BE
Patent application number | Description | Published |
---|---|---|
20090155309 | Novel vaccine - The invention relates to the use of a non-live influenza virus antigen preparation, particularly a split influenza virus preparation, in the manufacture of a vaccine formulation for a one-dose intranasal vaccination against influenza, wherein the one-dose vaccination meets international regulatory requirements for influenza vaccines. Further provided are methods for the production of the vaccine, and a pharmaceutical kit comprising an intranasal administration device and the one-dose vaccine. | 06-18-2009 |
20090263470 | Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant - This invention provides virosome preparations from an enveloped virus, in particular from influenza virus, containing from said virus, and a saponin adjuvant. In particular the invention provides a virosome preparation from influenza virus an influenza antigen a QS21, optionally with a sterol. The invention also provides vaccine compositions containing said virosome preparations, methods of preparing said virosome preparations and vaccine containing them. | 10-22-2009 |
20120087976 | ADJUVANT COMPOSITIONS COMPRISING A NON-IONIC ISOTONICITY AGENT - The present invention relates to an aqueous adjuvant composition comprising a TLR-4 agonist and a saponin in a liposomal formulation and a non-ionic isotonicity agent having low salt concentrations. | 04-12-2012 |
20120093921 | IMMUNOGENIC COMPOSITIONS HAVING LOW SODIUM CHLORIDE CONCENTRATION - Immunogenic compositions comprising an antigen, wherein the concentration of sodium chloride or the ionic strength of the composition is less than 100 mM, and their use in medicine, are provided. | 04-19-2012 |
20140112953 | INACTIVATED DENGUE VIRUS VACCINE - The present invention provides formulations of an immunogenic composition containing a purified inactivated Dengue virus, and method for producing them. | 04-24-2014 |
Veronique Larcher, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20110135098 | METHODS AND DEVICES FOR REPRODUCING SURROUND AUDIO SIGNALS - Method and devices for providing surround audio signals are provided. Surround audio signals are received and are binaurally filtered by at least one filter unit. In some embodiments, the input surround audio signals are also processed by at least one equalizing unit. In those embodiments, the binau-rally filtered signals and the equalized signals are combined to form output signals. | 06-09-2011 |
20140334650 | METHODS AND DEVICES FOR REPRODUCING SURROUND AUDIO SIGNALS - Method and devices for providing surround audio signals are provided. Surround audio signals are received and are binaurally filtered by at least one filter unit. In some embodiments, the input surround audio signals are also processed by at least one equalizing unit. In those embodiments, the binaurally filtered signals and the equalized signals are combined to form output signals. | 11-13-2014 |
Veronique Larreta-Garde, L'Isle Adam FR
Patent application number | Description | Published |
---|---|---|
20090029411 | Biomaterial Capable Of Successively Performing A Solution/Gel Transition And Then A Gel/Solution Transition - The invention relates to a biomaterial which can successively carry out a solution/gel transition then a gel/solution transition with given kinetics, said biomaterial comprising at least one monomer which may form polymers, at least on enzyme which may decompose said polymers and, optionally, an enzyme which may form covalent bonds between said monomers. The invention further relates to a method for the production of said biomaterial. | 01-29-2009 |
Veronique Lecault, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20120009671 | SYSTEM AND METHOD FOR MICROFLUIDIC CELL CULTURE - Microfluidic devices and methods for perfusing a cell with perfusion fluid are provided herein, wherein the gravitational forces acting on the cell to keep the cell at or near a retainer or a retaining position exceed the hydrodynamic forces acting on the cell to move it toward an outlet. | 01-12-2012 |
20130115606 | SYSTEM AND METHOD FOR MICROFLUIDIC CELL CULTURE - Microfluidic devices and methods for perfusing a cell with perfusion fluid are provided herein, wherein the gravitational forces acting on the cell to keep the cell at or near a retainer or a retaining position exceed the hydrodynamic forces acting on the cell to move it toward an outlet. Also provided, are methods for assaying cell products within the microfluidic device. | 05-09-2013 |
20150018226 | Microfluidic Cell Trap and Assay Apparatus for High-Throughput Analysis - Microfluidic devices are provided for trapping, isolating, and processing single cells. The microfluidic devices include a cell capture chamber having a cell funnel positioned within the cell capture chamber to direct a cell passing through the cell capture chamber towards one or more a cell traps positioned downstream of the funnel to receive a cell flowing. The devices may further include auxiliary chambers integrated with the cell capture chamber for subsequent processing and assaying of the contents of a captured cell. Methods for cell capture and preparation are also provided that include flowing cells through a chamber, funneling the cells towards a cell trap, capturing a predefined number of the cells within the trap, interrupting the flow of cells, flowing a wash solution through the chamber to remove contaminants from the chamber, and sealing the predefined number of cells in the chamber. | 01-15-2015 |
Veronique Legeais, Le Mans FR
Patent application number | Description | Published |
---|---|---|
20080206795 | Novel Supports, in Particular for Immunodetection of Molecules of Interest - The invention concerns supports or receptacles for solubilized or suspended biological entities whereof the walls are made of plastics surface-treated by an electromagnetic plasma followed by a polymer deposition. It can be in the form of tubes or multiple-well plates. It provides among other things the possibility of storing, transferring and performing reactions in the context of microassays of biological entities, more particularly the prion protein, with enhanced sensitivity. | 08-28-2008 |
Veronique Lemellay Hamon, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20100055059 | ASSOCIATION OF COMPOUNDS INHIBITING MELANOGENESIS AND USE THEREOF IN COSMETICS AND DERMATOLOGY - The invention relates to an association including at least : a MC1-R receptor inhibitor; a tyrosinase inhibitor derived from vitamin C; an inhibitor of the transfer of melanosomes to the keratinocytes; the invention also relates to the use thereof in cosmetics and dermatology for preparing whitening and/or bleaching depigmentation compositions. | 03-04-2010 |
Veronique Mainfroid, Waremme BE
Patent application number | Description | Published |
---|---|---|
20080214407 | METHOD AND SYSTEM FOR QUANTIFICATION OF A TARGET COMPOUND OBTAINED FROM A BIOLOGICAL SAMPLE UPON CHIPS - A method quantifies a target compound selected from the group consisting of a polynucleotide or a protein present in a sample solution. The method includes putting into contact a target compound with a capture probe and detecting signals resulting from the binding between the target compound and its corresponding capture probe and resulting from the printed detection molecule in the different discrete regions. The method obtains a detection curve of the detected signals of the detection molecule and converts the signal obtained from the target compound bound to a specific capture probe into a concentration value and quantifies the target compound by converting the concentration value into a target amount using a target concentration curve. | 09-04-2008 |
20100137144 | METHOD AND MEANS FOR DETECTING AND/OR QUANTIFYING HIERARCHICAL MOLECULAR CHANGE OF A CELL IN RESPONSE TO AN EXTERNAL STIMULUS - The present invention is related to a method for detecting and/or quantifying hierarchical (regulated) molecular changes of a cell in response to any external stimulus. | 06-03-2010 |
20100196358 | METHOD AND KIT TO PROFILE TUMORS BY BIOMARKER ANALYSES INCLUDING TRANSCRIPTIONAL FACTOR ASSAYS - The present invention is related to a method and kit (or device) for the detection and/or the quantification of biomarkers related to tumorigenesis. Said method is advantageously used to propose or adapt an anti-tumoral therapeutic protocol to be administered to a subject. Furthermore, said method and kit (or device) are a technical platform for the identification of new compounds, which are preferably used at (a) specific step(s) of an anti-tumoral therapeutic protocol. | 08-05-2010 |
Veronique Maquet, Berloz BE
Patent application number | Description | Published |
---|---|---|
20100003292 | FINE-GRANULOMETRY FUNGAL EXTRACT CHITINE-GLUCANE - The present invention relates to a chitin-glucan copolymer in the form of micrometric particles. | 01-07-2010 |
20110035023 | PROSTHESIS FOR PROMOTING THE IN VIVO RECONSTRUCTION OF A HOLLOW ORGAN OR A PORTION OF A HOLLOW ORGAN - The invention relates to a prosthesis for promoting the in vivo reconstruction of a hollow organ or of a portion of a hollow organ, characterized in that it comprises: | 02-10-2011 |
20130156836 | Chitosan Bornet - The invention relates to a chitosan as a micronized powder, to its use for controlling certain yeasts, such as | 06-20-2013 |
Veronique Mayaudon, Gognies-Chaussee FR
Patent application number | Description | Published |
---|---|---|
20090191537 | MEDIUM AND METHODS FOR THE STORAGE OF PLATELETS - Synthetic storage media are disclosed for use in the processing and the storing of platelets. The storage media includes a platelet storage solution and less than 20 percent plasma to preserve platelet function after at least 7 days of storage. | 07-30-2009 |
20090239208 | Red Blood Cell Storage Medium For Extended Storage - Synthetic aqueous storage solutions are disclosed for use in the processing and the storing of red blood cells prepared from whole blood including cells derived from whole blood held for an extended period at room temperature. | 09-24-2009 |
20110117647 | Red Blood Cell Storage Medium For Extended Storage - Synthetic aqueous storage solutions are disclosed for use in the processing and the storing of red blood cells prepared from whole blood including cells derived from whole blood held for an extended period at room temperature. | 05-19-2011 |
Veronique Moragues, Aincourt FR
Patent application number | Description | Published |
---|---|---|
20100094005 | FLUORINATED DERIVATIVE OF QUINOLIN-2(1H)-ONE, METHOD FOR PREPARING THE SAME AND USE THEREOF AS A SYNTHESIS INTERMEDIATE - The invention relates to a fluorinated derivate of quinolin-2(1H)-one (I), to a method for preparing the same, and to the use thereof as an intermediate in the synthesis of 7-fluoro-2-oxo-4-[2-[4-[thieno[3,2-c]pyridine-4-yl)piperazin-1-yl]ethyl]-1,2-dihydro-quinolin-1-acetamide. The invention also relates to the pharmaceutically acceptable salts thereof. | 04-15-2010 |
Veronique Morisson-Iveson, Buckinghamshire GB
Patent application number | Description | Published |
---|---|---|
20080260651 | CONTRAST AGENTS - The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds containing an aliphatic N-heterocyclic central moiety such as pyrrolidine or piperidine heterocycles allowing for the arrangement of three iodinated phenyl groups bound thereto. | 10-23-2008 |
20100189656 | CONTRAST AGENTS - The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds containing a triamine alkyl central moiety allowing for the arrangement of three iodinated phenyl groups bound thereto. The invention also relates to the use of such diagnostic compositions as contrast agents in diagnostic imaging and in particular in X-ray imaging and to contrast media containing such compounds. | 07-29-2010 |
20100221189 | CONTRAST AGENTS - The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds containing two linked iodinated phenyl groups of the general formula (I) and salts or optical active isomers thereof, wherein each R | 09-02-2010 |
Veronique Morisson-Iveson, Amersham GB
Patent application number | Description | Published |
---|---|---|
20100303734 | CONTRAST AGENTS - The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds containing two linked iodinated phenyl groups of the general formula (I): R—CO—N(R)—X—N(R)—CO—R and salts or optical active isomers thereof, wherein one R denotes a hydrogen atom or a C | 12-02-2010 |
20110206607 | IMIDAZOL (1,2-A)PYRIDINES AND RELATED COMPOUNDS WITH ACTIVITY AT CANNABINOID CB2 RECEPTORS - Disclosed herein are compounds of Formula (I), or a pharmaceutically acceptable salt, ester, amide, thereof; and methods of modulating the activity of a cannabinoid CB2 receptor comprising contacting a compound of Formula I with the cannabinoid CB2 receptor. Also disclosed are methods of imaging of a tissue by positron emission tomography, the method comprising administering to the subject a compound of Formula I, wherein the compound comprises a radioisotope. Also disclosed are methods of measuring the relative concentration of cannabinoid CB2 receptors in tissue of a subject, by using a compound of Formula I which comprises a radioisotope. In addition, method of diagnosing a disorder in a subject are disclosed. | 08-25-2011 |
Veronique Morrison-Iverson, Amersham GB
Patent application number | Description | Published |
---|---|---|
20100233097 | CONTRAST AGENTS - Compounds of formula (I) R | 09-16-2010 |
Veronique Morrison-Iveson, Amersham GB
Patent application number | Description | Published |
---|---|---|
20110027178 | IMAGING THE CENTRAL NERVOUS SYSTEM - The present invention provides novel compounds which may be used as in vivo imaging agents. The compounds of the invention are useful in a method to image the expression of P2X | 02-03-2011 |
Veronique Morrison-Iveson, Buckinghamshire GB
Patent application number | Description | Published |
---|---|---|
20100111875 | TRISUBSTITUTED TRIAZAMACROCYCLIC COMPOUNDS AND THEIR USE AS CONTRAST AGENTS - The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds containing a saturated triaza cyclic central moiety containing carbonyl functions allowing for the arrangement of three iodinated phenyl groups bound thereto. The invention also relates to the use of such diagnostic compositions as contrast agents in diagnostic imaging and in particular in X-ray imaging and to contrast media containing such compounds. | 05-06-2010 |
Veronique Mourier-Robert, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20110201695 | Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsion - The present invention relates to a therapeutic agent formulation in the form of a nano-emulsion, comprising a continuous aqueous phase and at least one dispersed oily phase, in which the oily phase comprises further to the therapeutic agent, at least one amphiphilic lipid and at least one solubilising lipid, and in which the aqueous phase comprises at least one polyalkoxylated cosurfactant. | 08-18-2011 |
Veronique Nouaze, Plessis Robinson FR
Patent application number | Description | Published |
---|---|---|
20090159276 | Methods and Apparatus for Communicating Across Casing - A system for passing an electromagnetic signal through a casing comprises a tool body that can be positioned inside the casing; means for magnetically saturating the casing in the vicinity of the tool; a transmitter for transmitting an electromagnetic signal from the tool antenna to the outside of the casing for reception at one or more sensors equipped with an antenna and electronic circuits located outside the casing; and a detector for detecting an electromagnetic signal at the tool from the sensor located outside the casing. | 06-25-2009 |
20100011853 | CONTACT-LESS SENSOR CARTRIDGE - The invention provides a sensor cartridge comprising: (a) a protective housing ( | 01-21-2010 |
Veronique Pancre, Orchies FR
Patent application number | Description | Published |
---|---|---|
20090130134 | T CD4+ Epitopes of Type I and II Latency Antigens of the Epstein-Barr Virus, Which Can Be Recognized by the majority of individuals in the caucasian populations and applications thereof - The invention relates to immunogenic peptides from EBV type I and II latency antigens, comprising at least one T CD4+ epitope which can be recognized by the majority of individuals in the Caucasian population. The invention also relates to the diagnostic and therapeutic applications of same. | 05-21-2009 |
20110067121 | Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications - The present invention-relates to transgenic mice and isolated transgenic mouse cells, the mice and mouse cells comprising a disrupted H2 class I gene, a disrupted H2 class II gene, a functional HLA class I transgene, and a functional HLA class II transgene. In embodiments, the transgenic mouse or mouse cells are deficient for both H2 class I and class II molecules, wherein the transgenic mouse comprises a functional HLA class I transgene and a functional HLA class II transgene. In embodiments, the transgenic mouse or mouse cell has the genotype HLA-A2 | 03-17-2011 |
20110142862 | TRANSGENIC MICE HAVING A HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PHENOTYPE, EXPERIMENTAL USES AND APPLICATIONS - The present invention relates to transgenic mice and isolated transgenic mouse cells, the mice and mouse cells comprising a disrupted H2 class I gene, a disrupted H2 class II gene, a functional HLA class I transgene, and a functional HLA class II transgene. In embodiments, the transgenic mouse or mouse cells are deficient for both H2 class I and class II molecules, wherein the transgenic mouse comprises a functional HLA class I transgene and a functional HLA class II transgene. In embodiments, the transgenic mouse or mouse cell has the genotype HLA-A2 | 06-16-2011 |
Veronique Parnet, Le Cannet FR
Patent application number | Description | Published |
---|---|---|
20100158843 | NOVEL 3-PHENYLPROPANOIC COMPOUND ACTIVATORS OF RECEPTORS OF PPAR TYPE AND PHARMACEUTICAL/COSMETIC COMPOSITIONS COMPRISED THEREOF - Novel 3-phenylpropanoic acid compounds have the general formula (I) below: | 06-24-2010 |
20110281913 | MELANOCORTIN RECEPTOR ANTAGONIST COMPOUNDS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS - Melanocortin receptor antagonist compounds, processes for preparing them and uses thereof in human medicine and cosmetics are described. | 11-17-2011 |
Veronique Perrier-Rondard, Jacou FR
Patent application number | Description | Published |
---|---|---|
20090130689 | Method useful for detecting encephalopathies - The invention concerns a method of detecting a TSSE Disease or prion disease. The invention further concerns a method for amplifying oligomerization of isoforms of the cellular prion PrP | 05-21-2009 |
Veronique Plantevin, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090099178 | INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF - This invention is directed to Indazole Compounds or pharmaceutically acceptable salts, solvates and hydrates thereof. The Indazole Compounds have utility in the treatment or prevention of a wide range of diseases and disorders that are responsive to the inhibition, modulation or regulation of kinases, such as inflammatory diseases, abnormal angiogenesis and diseases related thereto, cancer, atherosclerosis, a cardiovascular disease, a renal disease, an autoimmune condition, macular degeneration, disease-related wasting, an asbestos-related condition, pulmonary hypertension, diabetes, obesity, pain and others. Thus, methods of treating or preventing such diseases and disorders are also disclosed, as are pharmaceutical compositions comprising one or more of the Indazole Compounds. This invention is based, in part, upon the discovery of a novel class of 5-triazolyl substituted indazole molecules that have potent activity with respect to the modulation of protein kinases. Thus, the invention encompasses orally active molecules as well as parenterally active molecules which can be used at lower doses or serum concentrations for treating diseases or disorders associated with protein kinase signal transduction. | 04-16-2009 |
Veronique Plantevin-Krenitsky, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090275564 | HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH - Provided herein are Aminopurine Compounds having the following structure: | 11-05-2009 |
20090312320 | METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HALOARYL SUBSTITUTED AMINOPURINES OR COMPOSITIONS THEREOF - Provided herein are Aminopurine Compounds having the following structure: | 12-17-2009 |
20100093698 | AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH - Provided herein are Heteroaryl Compounds of formula (I): | 04-15-2010 |
20130005707 | AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH - Provided herein are Heteroaryl Compounds of formula (I): | 01-03-2013 |
20130225564 | HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF,AND METHODS OF TREATMENT THEREWITH - Provided herein are Aminopurine Compounds having the following structure: | 08-29-2013 |
20140206697 | HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF,AND METHODS OF TREATMENT THEREWITH - Provided herein are Aminopurine Compounds having the following structure: | 07-24-2014 |
Veronique Pugnet, Lyon FR
Patent application number | Description | Published |
---|---|---|
20110065942 | PROCESS FOR PREPARING ESTERS OF ALCOHOLS AND GLYCERIN FROM TRIGLYCERIDES AND ALCOHOLS USING A HETEROGENEOUS CATALYST IN THE PRESENCE OF A CONTROLLED QUANTITY OF WATER - A process for preparing a composition of alcoholic esters of straight chain monocarboxylic acids containing 6 to 26 carbon atoms and glycerin, starting from a vegetable or animal oil, neutral or acidic, virgin or recycled with mono-alcohols containing 1 to 18 atoms, in the presence of a zinc aluminate catalyst and in the presence of a controlled quantity of water, can directly produce, in one or more steps, an ester which can be used as a propellant or fuel along with glycerin having improved purity containing a reduced quantity of ethers by using a partially dried catalyst. | 03-17-2011 |
20110092730 | HETEROGENEOUS CATALYST OF THE ZINC ALUMINATE SPINEL TYPE SURSTOICHIOMETRIC IN ZINC AND USE THEREOF IN A PROCESS FOR PREPARATION OF ALCOHOL ESTERS FROM TRIGLYCERIDES AND ALCOHOLS - A catalyst with a mixed zinc and aluminium oxide base having a spinel structure surstoichiometric in zinc, in which part of the Zn atoms are in the octahedral position, a process for preparation of the same and use of the same in a process for preparation of a compound of linear monocarboxylic acid alcohol esters with 6-26 carbon atoms from a vegetable or animal oil, neutral or acid, virgin or recycled, with monoalcohols of 1-18 carbon atoms allowing an ester that can be used as a motor fuel or a heating fuel and a pure glycerine to be obtained directly in one or more steps, | 04-21-2011 |
Veronique Rebeyrolle, Duingt FR
Patent application number | Description | Published |
---|---|---|
20100091932 | METHOD FOR DESIGNING A FUEL ASSEMBLY OPTIMIZED AS A FUNCTION OF THE STRESSES IN USE IN LIGHT-WATER NUCLEAR REACTORS, AND RESULTING FUEL ASSEMBLY - A method for design of a fuel assembly for nuclear reactors, including structural components made from zirconium alloy: the mean uniaxial tensile or compressive stress to which the components are subjected during the assembly life is calculated, the zirconium alloy of which the components are made is selected according to the following criteria: those components subjected to an axial or transverse compressive stress of between −10 et −20 MPa are made from an alloy with a content of Sn between Sn=(=0.025σ−0.25)% and Sn=−0.05σ%: those components subjected to such a stress of between 0 et −10 MPa are made from an alloy the Sn content of which is between Sn=traces and Sn=(0.05σ+1)%: those components subjected to such a stress of between 0 and +10 MPa are made from an alloy the Sn content of which is between Sn=0.05% and Sn=(0.07σ+1)%: and those components subjected to such a stress of between +10 and +20 MPa are made from an alloy the content of SN of which is between 0.05% and 1.70%. A fuel assembly made according to the method. | 04-15-2010 |
20100126636 | ZIRCONIUM ALLOY RESISTANT TO CORROSION IN DROP SHADOWS FOR A FUEL ASSEMBLY COMPONENT FOR A BOILING WATER REACTOR, COMPONENT PRODUCED USING SAID ALLOY, FUEL ASSEMBLY, AND USE OF SAME - A zirconium alloy that is resistant to shadow corrosion for a boiling water nuclear reactor fuel assembly component, the alloy being characterized in that: | 05-27-2010 |
Veronique Rebuffel, Corenc FR
Patent application number | Description | Published |
---|---|---|
20100038548 | GAMMA-CAMERA UTILIZING THE INTERACTION DEPTH IN A DETECTOR - A method for reconstructing an image of a source (S) of photons from interactions of photons emitted by this source with a detector ( | 02-18-2010 |
20120239310 | METHOD AND DEVICE FOR RECOGNITION OF A MATERIAL MAKING USE OF ITS TRANSMISSION FUNCTION - A method for characterising nature of a material, including: providing at least one sample of the material between an X-ray source and a detector; using the X-ray source to make N X-radiation spectra transmitted through the material, each for a time; calculating transmission function of the material as a function of energy or the detection channel; and in each of at least two energy zones, calculating the integral of the transmission function, thus forming at least a first transmission coefficient and a second transmission coefficient. | 09-20-2012 |
20130110438 | METHOD OF IDENTIFYING MATERIALS FROM MULTI-ENERGY X-RAYS | 05-02-2013 |
20140126693 | METHOD AND DEVICE FOR IDENTIFYING A MATERIAL BY THE SPECTRAL ANALYSIS OF ELECTROMAGNETIC RADIATION PASSING THROUGH SAID MATERIAL - A method identifying a material, includes: measuring an electromagnetic radiation spectrum emitted through the material; determining at least one measurement energy band, and spectral coefficients of a comparison function in the measurement band, using the measured spectrum; estimating, using the determined spectral coefficients, a nature and/or thickness of the material based on a set of reference spectral parameters relating to reference materials and/or thicknesses and defined in reference bands. The estimating includes: prior selecting plural reference materials and/or thicknesses, as possible candidates, from comparing the spectral coefficients determined with at least one portion of the reference spectral parameters; estimating the nature and/or thickness of the material from comparing the spectral coefficients determined with the spectral parameters of at least one portion of the possible candidates, in at least one energy band common to the reference bands of the at least one portion of possible candidates and the measurement band. | 05-08-2014 |
20140319364 | Photonic Radiation Detection Device, And Methods For Dimensioning And Operating Such Device - A photonic radiation detection device includes a collimator, a detector, and localization means for determining information relative to the localization of a photon interaction with the detector material. In at least one previously selected acquisition configuration, a degree of pixelation in the detection plane is greater than 1 and a collimator-detector distance (C) is greater than one tenth of the septal height (h) of the collimator where the septal height is a maximum dimension of the collimator in a direction orthogonal to the frontal detection plane. In one instance, the septal wall thickness (e) is one of about 0.1 or less than about 0.1 of the channel width (w). In another instance, the collimator-detector distance is greater than h/(2(w/e−1)). A dimensioning method includes, for at least one given spatial frequency, calculating and comparing merit indicator values for different acquisition configurations of a structural model of the detection device. | 10-30-2014 |
Veronique Roan, Tournefeuille FR
Patent application number | Description | Published |
---|---|---|
20090105943 | METHOD AND DEVICE FOR CREATING AN AIRCRAFT FLIGHT PLAN | 04-23-2009 |
Veronique Rochus, Liege BE
Patent application number | Description | Published |
---|---|---|
20120127558 | DIFFRACTIVE OPTICAL NANO-ELECTRO-MECHANICAL DEVICE WITH REDUCED DRIVING VOLTAGE - A DND device is disclosed. In one aspect, the device includes a nano-mirror ( | 05-24-2012 |
20130187669 | Calibration of Micro-Mirror Arrays - A built-in self-calibration system and method for a micro-mirror array device, for example, operating as a variable focal length lens is described. The calibration method comprises determining a capacitance value for each micro-mirror element in the array device at a number of predetermined reference angles to provide a capacitance-reference angle relationship. From the capacitance values, an interpolation step is carried to determine intermediate tilt angles for each micro-mirror element in the array. A voltage sweep is applied to the micro-mirror array and capacitance values, for each micro-mirror element in the array, are measured. For a capacitance value that matches one of the values in the capacitance-reference angle relationship, the corresponding voltage is linked to the associated tilt angle to provide a voltage-tilt angle characteristic which then stored in a memory for subsequent use. | 07-25-2013 |
20140292323 | Two Axes MEMS Resonant Magnetometer - A two-axes MEMS magnetometer includes, in one plane, a freestanding rectangular frame having inner walls and four torsion springs, wherein opposing inner walls of the frame are contacted by one end of only two torsion springs, each torsion spring being anchored by its other end, towards the centre of the frame, to a substrate. In operation, the magnetometer measures the magnetic field in two orthogonal sensing modes using differential capacitance measurements. | 10-02-2014 |
20140368920 | Micro-Mirror Arrays - Micro-mirror arrays configured for use in a variable focal length lens are described herein. An example variable focal length lens comprises a micro-mirror array having a plurality of micro-mirror element arranged in at least a first section and a second section. Each micro-mirror element has a tilt axis and comprises, on each of two opposing sides of the tilt axis, (i) at least one actuation electrode, (ii) at least one measurement electrode, and (iii) at least one stopper. Additionally, each micro-mirror element in the first section has a first tilt axis range, and each micro-mirror element in the second section has a second tilt axis range, with the first tilt axis range being less than the second tilt axis range. | 12-18-2014 |
Veronique Rogemond, Lyon FR
Patent application number | Description | Published |
---|---|---|
20080226636 | Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes - A purified polypeptide, designated ULIP6, comprising the amino acid sequence SEQ ID No. 2 or an epitopic fragment of said polypeptide, comprising the sequence SEQ ID No. 4, is provided along with its nucleic acid sequences. In addition, antibodies to the polypeptide and methods of diagnosing paraneoplastic neurological syndromes and/or for the early diagnosis of the formation of cancerous tumors are also provided. | 09-18-2008 |
20130243755 | NOVEL HUMAN ULIP/CRMP PROTEIN AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF CANCERS AND PARANEOPLASTIC NEUROLOGICAL SYNDROMES - A purified polypeptide, designated ULIP6, comprising the amino acid sequence SED ID No. 2 or an epitopic fragment of said polypeptide, comprising the sequence SEQ ID No. 4, is provided along with its nucleic acid sequences. In addition, antibodies to the polypeptide and methods of diagnosing paraneoplastic neurological syndromes and/or for the early diagnosis of the formation of cancerous tumors are also provided. | 09-19-2013 |
20150018251 | PROTEIN CHIPS, PREPARATION AND USE THEREOF - The present invention relates to the field of medicine, in particular of research and diagnosis. It relates more particularly to a novel tool for detecting antibodies in a biological sample originating from a mammal. This tool, which is in the form of a protein chip, can be used in screening for new targets of interest involved in the occurrence of an autoimmune disease, in particular of a disease affecting the nervous system of a mammal, and also in the diagnosis or the monitoring of the progression of such an autoimmune disease. The invention also relates to a method for producing such a tool and also to kits comprising it and enabling its use. | 01-15-2015 |
Veronique Roulier, La Varenne St Hilaire FR
Patent application number | Description | Published |
---|---|---|
20090206174 | DEVICE FOR SPRAYING A COSMETIC COMPOSITION - The present invention relates to a cosmetic assembly comprising a cosmetic or dermatological composition contained in a reservoir, the said composition being liquid and comprising, in a physiologically acceptable medium, at least 10% by weight of water and at least one water-soluble coloring agent; and a device for spraying a cosmetic composition, comprising a container containing the said liquid cosmetic composition, equipped with a piezoelectric spraying mechanism for spraying the cosmetic composition in the form of droplets. | 08-20-2009 |
Veronique Roulleaux, Saint Raphael FR
Patent application number | Description | Published |
---|---|---|
20120004357 | AQUEOUS FORMULATION FOR AN ANTIFOULING COATING SYSTEM FOR SUBMERGED SUBSTRATES, METHOD FOR TREATING SAME, AND USE THEREOF - The invention relates to a formulation for an antifouling coating system to be applied on submerged substrates. The invention is characterised in that the formulation contains at least 30 wt % of water relative to the total weight thereof, at least 10 wt % relative to the total weight thereof of a dry extract of a waterproofing agent selected from a silicone resin, a polyurethane resin, and/or a styrene acrylic copolymer resin either alone or mixed, and at least 5 wt % relative to the total weight thereof of a dry extract of an active anti-adhesion agent. The invention also relates to a method for processing substrates to be submerged using such a formulation, and to the use of such a formulation as an antifouling agent for deterring the attachment of marine organisms such as algae, shellfish and other crustaceans on any submerged substrate, and in particular ship hulls. | 01-05-2012 |
Veronique Sardoy, Saint Julien Metz FR
Patent application number | Description | Published |
---|---|---|
20110168300 | MANUFACTURING METHOD FOR VERY HIGH-STRENGTH COLD-ROLLED DUAL-PHASE STEEL SHEETS AND SHEETS SO PRODUCED - The invention relates to a cold-rolled and annealed Dual-Phase steel sheet having a strength between 980 and 1100 MPa, and a breaking elongation greater than 9%, of which the composition comprises, the contents being expressed by weight: 0.055%≦C≦0.095%, 2%≦Mn≦2.6%, 0.005%≦Si≦0.35%, S≦0.005%, P≦0.050%, 0.1≦Al≦0.3%, 0.05%≦Mo≦0.25%, 0.2%≦Cr≦0.5%, it being understood that Cr+2Mo≦0.6%, Ni≦0.1%, 0.010≦Nb≦0.040%, 0.010≦Ti≦0.050%, 0.0005≦B≦0.0025%, and 0.002%≦N≦0.007%, the remainder of the composition consisting of iron and the inevitable impurities resulting from the smelting. | 07-14-2011 |
Veronique Sauvonnet, Courtenay FR
Patent application number | Description | Published |
---|---|---|
20110171667 | REACTION MEDIUM FOR DETECTING AND/OR IDENTIFYING BACTERIA OF THE LEGIONELLA GENUS - A reaction medium for the culture and/or detection and/or identification of bacteria of the | 07-14-2011 |
Veronique Sins, Grimbergen BE
Patent application number | Description | Published |
---|---|---|
20090123677 | Composite dough can recyclable as an all-paper product - A refrigerated dough container that has less than 5% non-paper material by weight such that the container qualifies as being a recyclable paper article. The container includes a paperboard body ply and a liner ply adhered to the inner surface of the body ply. The liner ply consists of a paper layer having an outer surface adhered to the inner surface of the container body, and at least one non-paper layer imparting moisture/gas barrier and sealing characteristics to the liner. The total weight of the non-paper layer(s) does not exceed 5% of the combined body ply and liner ply weight. The non-paper layers can include a metallized film or thin foil as a barrier layer and a polyolefin or sealing varnish as a sealant layer. Alternatively, a single non-paper layer, namely a PVDC layer, can be extrusion-coated onto the paper layer. | 05-14-2009 |
Veronique Van Pee, Vilvoorde BE
Patent application number | Description | Published |
---|---|---|
20110003234 | Polymer Composition, Polymer Membrane Comprising the Polymer Composition, Process for Preparing it and Fuel Cell Comprising the Membrane - A polymer composition comprising (a) a polybenzimidazole derived from (a1) at least one bis-(ortho-diamino) aromatic compound and (a2) at least one aromatic carboxylic acid or derivative thereof, each containing at least two acid groups and at least one hydroxyl group in α-position of a carboxylic group; (b) orthophosphoric acid; and (c) polyphosphoric acids of the formula (I): HO[P(O)(OH)] | 01-06-2011 |
20130331577 | PREPARATION OF A FAC-ISOMER FOR A TRIS HOMOLEPTIC METAL COMPLEX - The present application provides a use of a mixture comprising less than 75 vol. % of an organic solvent and more than 25 vol. % of water in a preparation of a fac-isomei of a tris homoleptic metal complex, in the presence or the absence of an added salt, and with the proviso that when an added salt contains at least two oxygen atoms, it is used in an amount such that the molar ratio of the salt to the metal in a metal compound used as starting material is less than 1. The present application also provides a method of preparing a fac-isomer for a tris homoleptic metal complex using the mixture. | 12-12-2013 |
Veronique Zennou, Paris FR
Patent application number | Description | Published |
---|---|---|
20100221820 | Use of triplex structure DNA in transferring nucleotide sequences - The invention concerns a recombinant vector characterised in that it comprises a polynucleotide comprising a central initiation cis-active region (cPPT) and a termination cis-active region (CTS), said regions being of retroviral or retroviral-like origin, said vector further comprising a predetermined nucleotide sequence (transgene or nucleotide sequence of interest) and retranscription regulating, expressing and packaging signals of retroviral or retroviral-like origin. | 09-02-2010 |
20120122204 | LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA - The present invention provides nucleic acid, vectors, viruses, and recombinant cells comprising triple-stranded structures, such as those resulting from central initiation and termination of HIV-1 reverse transcription at the center of HIV-1 linear DNA genomes. These triplex structures can act as a cis-determinant of HIV-1 DNA nuclear import, allowing infection of non-dividing target cells. In one aspect, the presence of the DNA triplex sequence in an HIV vector strongly stimulates gene transfer in hematopoietic stem cells. The invention also provides methods of using these triplex structures for making recombinant cells, as well as methods of using the recombinant cells to express proteins of interest both in vitro and in vivo. | 05-17-2012 |
20120122963 | LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA - The present invention provides nucleic acid, vectors, viruses, and recombinant cells comprising triple-stranded structures, such as those resulting from central initiation and termination of HIV-1 reverse transcription at the center of HIV-1 linear DNA genomes. These triplex structures can act as a cis-determinant of HIV-1 DNA nuclear import, allowing infection of non-dividing target cells. In one aspect, the presence of the DNA triplex sequence in an HIV vector strongly stimulates gene transfer in hematopoietic stem cells. The invention also provides methods of using these triplex structures for making recombinant cells, as well as methods of using the recombinant cells to express proteins of interest both in vitro and in vivo. | 05-17-2012 |
20130157357 | LENTIVIRAL VECTORS FOR THE PREPARATION OF IMMUNOTHERAPEUTICAL COMPOSITIONS - The invention relates to an immunogenic composition comprising a recombinant vector characterized in that it comprises a polynucleotide comprising the cis-acting central initiation region (cPPT) and the cis-acting termination region (CTS), these regions being of retroviral or retroviral-like origin, said vector comprising in addition a defined nucleotide sequence (transgene or sequence of interest) and regulatory signals of retrotranscription, expression and encapsidation of retroviral or retroviral-like origin, wherein the composition is capable of inducing or of stimulating a cell-mediated response for instance a CTL (Cytotoxic T Lymphocytes) response or a CD4 response, against one or several epitopes encoded by the transgene sequence present in the vector. | 06-20-2013 |
Véronique Arnoult Delest, Antony FR
Patent application number | Description | Published |
---|---|---|
20120251664 | FRESH DAIRY PRODUCTS WITH SATIETOGENIC POWER AND METHODS FOR PREPARING SAME - The invention concerns a fresh dairy product with low fat and sugar content and low energy density, comprising one or several satietogenic ingredients, as well as a method for making such a product. Said satietogenic ingredient(s) comprise proteins, in particular milk proteins and preferably serum milk proteins, associated with water-soluble dietary fibers and preferably viscosifying water-soluble dietary fibers. | 10-04-2012 |
Véronique Barban, Craponne FR
Patent application number | Description | Published |
---|---|---|
20100137571 | DENGUE SEROTYPE 1 ATTENUATED STRAIN - The invention relates to live attenuated VDV1 (VERO-Derived Dengue serotype 1 virus) strains which have been derived from the wild-type dengue-1 strain 16007 by passaging on PDK and sanitization on Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV1 strain. | 06-03-2010 |
20100174057 | DENGUE SEROTYPE 2 ATTENUATED STRAIN - The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV2 strain. | 07-08-2010 |
20100221285 | Method of Immunization Against the 4 Dengue Serotypes - The invention relates to a method for inducing a homologous protection against the 4 dengue serotypes in a patient, comprising the sequential administration, to said patient, (i) of a dose of a vaccinal dengue virus of a first serotype and of a dose of a vaccinal dengue virus of a second serotype, and (ii) of a dose of a vaccinal dengue virus of a third serotype and of a dose of a vaccinal dengue virus of a fourth serotype, in which the vaccinal dengue viruses (ii) are administered at least 30 days and at most 1 year after administration of the vaccinal viruses (i). | 09-02-2010 |
20100270202 | Method of Immunization Against the 4 Dengue Serotypes - The invention relates to a method for inducing a protection against the 4 dengue serotypes in a patient, comprising | 10-28-2010 |
20120083584 | DENGUE SEROTYPE 1 ATTENUATED STRAIN - The invention relates to live attenuated VDV1 (VERO-Derived Dengue serotype 1 virus) strains which have been derived from the wild-type dengue-1 strain 16007 by passaging on PDK and sanitization on Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV1 strain. | 04-05-2012 |
20120083585 | DENGUE SEROTYPE 2 ATTENUATED STRAIN - The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV2 strain. | 04-05-2012 |
Véronique Barban, Craponne FR
Patent application number | Description | Published |
---|---|---|
20100137571 | DENGUE SEROTYPE 1 ATTENUATED STRAIN - The invention relates to live attenuated VDV1 (VERO-Derived Dengue serotype 1 virus) strains which have been derived from the wild-type dengue-1 strain 16007 by passaging on PDK and sanitization on Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV1 strain. | 06-03-2010 |
20100174057 | DENGUE SEROTYPE 2 ATTENUATED STRAIN - The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV2 strain. | 07-08-2010 |
20100221285 | Method of Immunization Against the 4 Dengue Serotypes - The invention relates to a method for inducing a homologous protection against the 4 dengue serotypes in a patient, comprising the sequential administration, to said patient, (i) of a dose of a vaccinal dengue virus of a first serotype and of a dose of a vaccinal dengue virus of a second serotype, and (ii) of a dose of a vaccinal dengue virus of a third serotype and of a dose of a vaccinal dengue virus of a fourth serotype, in which the vaccinal dengue viruses (ii) are administered at least 30 days and at most 1 year after administration of the vaccinal viruses (i). | 09-02-2010 |
20100239612 | Method of Immunization Against the 4 Serotypes of Dengue Fever - The invention relates to a method for inducing protection against the 4 serotypes of dengue fever in a patient, comprising: | 09-23-2010 |
20100270202 | Method of Immunization Against the 4 Dengue Serotypes - The invention relates to a method for inducing a protection against the 4 dengue serotypes in a patient, comprising | 10-28-2010 |
20150031857 | DENGUE SEROTYPE 2 ATTENUATED STRAIN - The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV2 strain. | 01-29-2015 |
Véronique Bellon Maurel, Grabels FR
Patent application number | Description | Published |
---|---|---|
20120229809 | SELF-CONTAINED AND PORTABLE OPTICAL SPECTROMETER - The invention relates to a portable and self-contained optical spectrometer for analyzing a light spectrum backscattered by an illuminated sample, in order to deduce the content of at least one compound constituting the sample, said spectrometer being arranged about an optical axis and including: a target area centered on said optical axis; a plurality of optical sensors trained on the target area; an opaque measurement chamber including: an opening centered on said optical axis; at least one diffusing filter blocking said opening; and an inner bottom capable of housing the plurality of optical sensors and a main illumination device capable of illuminating the sample. The invention further relates to a method for using such a spectrometer. | 09-13-2012 |
Véronique Bonnelye, Conflans FR
Patent application number | Description | Published |
---|---|---|
20110147285 | REVERSE-OSMOSIS WATER DESALINATION PLANT - The invention relates to a reverse-osmosis water desalination plant comprising: a reverse-osmosis membrane unit (TP); at least one high-pressure pump (HP); a pressure-exchange-type energy collector (SRE) capable of transferring pressure from the concentrate leaving the membrane unit to a portion of the water to be treated; sensors for various operating parameters, in particular pressure, flow rate, temperature and salinity level, said sensors being provided at suitable locations; and control loops so that the various adjustable elements are maintained at a setpoint value. The plant also includes a secondary control system (D) comprising calculation means ( | 06-23-2011 |
Véronique Bonnelye, Conflans Sainte Honorine FR
Patent application number | Description | Published |
---|---|---|
20110290723 | METHOD AND PLANT FOR MANAGING THE CLOGGING OF MEMBRANE MODULES AND FILTRATION MEMBRANES - The invention relates to a method for managing the plugging of membrane modules and of filtration membranes, in particular for nanofiltration, ultrafiltration or reverse osmosis for desalinating water, which comprises carrying out consecutive rinsing operations for controlling clogging, in particular biological clogging: evaluating the thickness of the biofilm; starting a rinsing operation at the latest when the evaluated thickness of the biofilm exceeds a first predetermined setpoint value for the biofilm thickness and stopping the rinsing operation not before the biofilm thickness has become lower than a second predetermined setpoint value lower than the first one for the biofilm thickness. | 12-01-2011 |
Véronique Bonnelye, F-Conflans Sainte Honorine FR
Patent application number | Description | Published |
---|---|---|
20110186512 | PROCESS FOR DISINFECTING A FILTRATION WORKS FOR PRETREATMENT OF SALTWATER, AND INSTALLATION FOR THE IMPLEMENTATION THEREOF - Method for disinfecting a filtration works (F) for the pretreatment of salt water, particularly seawater, upstream of a water desalination unit ( | 08-04-2011 |
Véronique Bordas, Antony FR
Patent application number | Description | Published |
---|---|---|
20110293665 | Recombinant Der P 2 Expressed in Pichia Pastoris as a "Natural-Like" Allergen for Immunotherapy and Diagnostic Purposes - The present invention concerns a method for producing a recombinant | 12-01-2011 |
Véronique Bossennec, Serezin Du Rhone FR
Patent application number | Description | Published |
---|---|---|
20100152324 | COMPOSITION STABILIZED WITH RESPECT TO LIGHT AND/OR HEAT - The present invention relates to a polyamide-based composition stabilized with respect to light and/or heat comprising at least one stabilizer exhibiting at least one hindered amine functional group. The invention also relates to yarns, fibres, filaments and/or articles obtained from this composition. | 06-17-2010 |
20120046439 | PROCESS FOR THE MANUFACTURE OF A SOLUTION OF SALTS OF DIACIDS/DIAMINE(S) - A method for manufacturing a solution of a diacid and diamine salt for manufacturing polyamide is described. A method for manufacturing an aqueous solution of diacid and diamine salts produced by mixing at least two diacids and at least one diamine, with a weight concentration of salt between 40% and 70%, including, in a first step, preparing an aqueous solution of diacid(s) and diamine(s) with a diacid/diamine mole ratio of less than 1 using one diacid and one diamine, and in a second step, adjusting the mole ratio of diacids/diamine(s) to a value of between 0.9 and 1.1, and fixing the weight concentration of salt by adding another diacid and, optionally, additional water and/or diamine is also described. | 02-23-2012 |
Véronique Bossennec, Serezin Du Rhone FR
Patent application number | Description | Published |
---|---|---|
20090246448 | THERMOPLASTIC POLYMER/COLORANT TOW AND FLOCKED ARTICLES PREPARED THEREFROM - A continuous filament thermoplastic polymer/colorant tow, the filaments of which are formed from a composition containing at least one matrix including a thermoplastic polymer and a colorant, and, optionally, at least one light and/or heat stabilizer, and is converted into useful flocked articles, e.g., vehicle interiors, having such properties as good light and/or heat fastness. | 10-01-2009 |
20100152324 | COMPOSITION STABILIZED WITH RESPECT TO LIGHT AND/OR HEAT - The present invention relates to a polyamide-based composition stabilized with respect to light and/or heat comprising at least one stabilizer exhibiting at least one hindered amine functional group. The invention also relates to yarns, fibres, filaments and/or articles obtained from this composition. | 06-17-2010 |
Véronique Carron, Claix FR
Patent application number | Description | Published |
---|---|---|
20100117238 | METHOD FOR PREPARING A LAYER COMPRISING NICKEL MONOSILICIDE NISI ON A SUBSTRATE COMPRISING SILICON - The invention relates to a method for fabricating a layer comprising nickel monosilicide NiSi on a substrate comprising silicon successively comprising the following steps: | 05-13-2010 |
Véronique Carron, Claix FR
Patent application number | Description | Published |
---|---|---|
20100117238 | METHOD FOR PREPARING A LAYER COMPRISING NICKEL MONOSILICIDE NISI ON A SUBSTRATE COMPRISING SILICON - The invention relates to a method for fabricating a layer comprising nickel monosilicide NiSi on a substrate comprising silicon successively comprising the following steps: | 05-13-2010 |
20110143534 | METHOD FOR FORMING METALLIC MATERIALS COMPRISING SEMI-CONDUCTORS - The method for forming first and second metal-based materials comprises providing a substrate comprising an area made from a first semi-conductor material and an area made from a second semi-conductor material comprising germanium separated by a pattern made from dielectric material, depositing a metal layer and performing a first heat treatment in an atmosphere comprising a quantity of oxygen comprised between 0.01% and 5%. The metal layer reacts with the first semi-conductor material and the second semi-conductor material comprising germanium to respectively form the first metal-based material and the second metal-based material containing germanium. | 06-16-2011 |
Véronique Charpeignet, Toulon FR
Patent application number | Description | Published |
---|---|---|
20120110265 | SECURISATION OF A REMOTE EXECUTABLE CODE USING A FOOTPRINT OF THE COMPUTER RECIPIENT - Method of securing exchanges between two electronic devices, by using an imprint of at least one of the two devices. This imprint is obtained on the basis of all or part of the electronic components of which this device is composed. This imprint will serve, either to protect the confidentiality of the data exchanged, or to attest to the identity of the device issuing the data. | 05-03-2012 |
Véronique Conedera, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20130321533 | INK JET DEVICE COMPRISING MEANS FOR INJECTING A GAS WITH THE INK, AND ASSOCIATED INK JET METHOD - The invention relates to an ink jet device and to an associated method. Said device ( | 12-05-2013 |
20130328982 | INK JET DEVICE COMPRISING FLUID EXTRACTION MEANS, AND ASSOCIATED INK JET METHOD - The invention relates to an ink jet device and to an associated ink jet method. The ink jet device comprises at least one ink jet head ( | 12-12-2013 |
Véronique Delcenserie, Ontario BE
Patent application number | Description | Published |
---|---|---|
20100310513 | BIFIDOBACTERIAL SPECIES - New bacterium GC61 belonging to the genus | 12-09-2010 |
Véronique Delcenserie, Ontario BE
Patent application number | Description | Published |
---|---|---|
20100310513 | BIFIDOBACTERIAL SPECIES - New bacterium GC61 belonging to the genus | 12-09-2010 |
Véronique Dennin, Villeneuve D'Ascq FR
Patent application number | Description | Published |
---|---|---|
20100322964 | BACTERIAL COMPOSITION AND ITS USE - The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of | 12-23-2010 |
20120135036 | BACTERIAL COMPOSITION AND ITS USE - The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of | 05-31-2012 |
Véronique Dennin, Villeneuve D'Ascq FR
Patent application number | Description | Published |
---|---|---|
20100322964 | BACTERIAL COMPOSITION AND ITS USE - The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of | 12-23-2010 |
Véronique Dentan, Paris FR
Patent application number | Description | Published |
---|---|---|
20120035484 | USE OF A SYSTEM FOR IMAGING BY FIBER-OPTIC CONFOCAL FLUORESCENCE IN VIVO IN SITU, SYSTEM AND METHOD FOR IMAGING BY FIBER-OPTIC CONFOCAL FLUORESCENCE IN VIVO IN SITU - A method for imaging a tissue includes collecting a light signal from at least part of said tissue, using a fiber optic probe for fluorescence imaging, wherein the fiber optic probe comprises a plurality of optic fibers, and wherein a distal tip of the fiber optic probe is placed at a distance from said tissue, said imaging being made confocal at a proximal tip of said fiber optic probe. A fluorescence imaging system includes an endoscope equipped with a working channel, in which a fiber optic probe has been inserted, wherein the fiber optic probe is movable between a retracted position and at least one position of extension, said fiber optic probe comprising a plurality of optic fibers for performing imaging of a tissue, said imaging being confocal via a processor located at a proximal tip of said fiber optic probe. | 02-09-2012 |
Véronique Dewynter-Marty, Gif S/yvette FR
Patent application number | Description | Published |
---|---|---|
20100290062 | Microstructured fibre bragg grating sensor - The invention involves a sensor ( | 11-18-2010 |
Véronique Dewynter-Marty, Gif S/yvette FR
Patent application number | Description | Published |
---|---|---|
20100290062 | Microstructured fibre bragg grating sensor - The invention involves a sensor ( | 11-18-2010 |
Véronique Ducandas, Vitry Sur Seine FR
Patent application number | Description | Published |
---|---|---|
20110152311 | NOVEL CRYSTALLINE FORMS OF TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE SODIUM SALT - The present invention relates to novel crystalline forms of sodium salt of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide (e.g., NXL-104) thereof. The present invention relates to compositions comprising a crystalline form of sodium salt of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide (e.g., NXL-104) alone or in combination with an antibacterial agent (e.g., ceftaroline fosamil). Processes for the preparation of the crystalline forms and methods of treating bacterial infections by administering the crystalline forms alone or in combination with an antibacterial agent (e.g., ceftaroline fosamil) are also described. | 06-23-2011 |
Véronique Durieu, Sombreffe BE
Patent application number | Description | Published |
---|---|---|
20100292188 | Compounds Comprising A Cyclobutoxy Group - The present invention relates to compounds of formula (I) comprising a cyclobutoxy group, processes for preparing them, pharmaceutical compositions comprising said compounds and their use as pharmaceuticals. | 11-18-2010 |
Véronique Durieu, Sombreffe BE
Patent application number | Description | Published |
---|---|---|
20100292188 | Compounds Comprising A Cyclobutoxy Group - The present invention relates to compounds of formula (I) comprising a cyclobutoxy group, processes for preparing them, pharmaceutical compositions comprising said compounds and their use as pharmaceuticals. | 11-18-2010 |
Véronique Gelsi-Boyer, Marseille FR
Patent application number | Description | Published |
---|---|---|
20130059301 | ASXL1 AS A NEW DIAGNOSTIC MARKER OF MYELOID NEOPLASMS - A method for diagnosing a myeloid cancer in a subject, includes the step of analyzing a biological sample from the subject by determining the presence or the absence of a mutation in the ASXL1 (additional sex combs like 1) gene coding for the polypeptide having the sequence SEQ ID N°2. A kit for diagnosing myeloid cancer in a subject including at least one nucleic acid probe or oligonucleotide or at least one antibody, which can be used in a such a method is also described. | 03-07-2013 |
Véronique Gomord, Rouen FR
Patent application number | Description | Published |
---|---|---|
20090312240 | Synthesis of Sialic Acid in Plants - A method of synthesizing sialic acid in plants, and plants capable of synthesizing sialic acid is provided. Furthermore, a method of producing sialylated a protein in a plant is also provided. The method to synthesize sialic acid comprises providing a plant comprising a nucleotide sequence encoding N-acetyl neuraminic acid (Neu5Ac) synthase or Neu5Ac lyase, and expressing the nucleotide sequence thereby synthesizing sialic acid. The plant may also co-express a nucleotide sequence encoding one or more than one of an epimerase, a CMP-Neu5 Ac synthase, CMP-Neu5Ac transporter and a sialyltransferase. | 12-17-2009 |
20110195452 | SET OF SEQUENCES FOR TARGETING EXPRESSION AND CONTROL OF THE POST-TRANSLATIONAL MODIFICATION OF A RECOMBINANT POLYPEPTIDE - The present invention provides new tools useful for controlling the post-translational modifications of recombinant polypeptides. These tools are particular signal peptides allowing the targeting of recombinant polypeptides during their synthesis in a host cell to specific sub-cellular compartments and a specific designing of said recombinant polypeptides within said sub-cellular compartments. These signal peptides are SEQ ID no 1 to SEQ ID no 31 disclosed herein. The present invention relates therefore also to a process for producing a recombinant polypeptide, in particular to a post-translationally modified polypeptide comprising the steps of transfecting or transforming a cell with at least one numleic acid vector encoding a recombinant protein which is the polypeptide before being post-translationally modified or a recombinant protein different to said polypeptide, said recombinant protein comprising a peptide signal according to the present invention; growing the transfected cell; and harvesting the post-translationally modified polypeptide; wherein, when said recombinant protein is different to said polypeptide, the method also comprises a step of transfecting said cell with at least one vector encoding said polypeptide. The present invention allows advantageously, for example, to increase the yield of production of recombinant polypeptides, to prevent immunogenicity if recombinant polypeptides and to obtain therapeutically active recombinant polypeptides that are the exact copy of their natural counterpart. This invention relates particularly to the field of reorientation of plants made pharmaceuticals (PMP). | 08-11-2011 |
Véronique Grenier-Caussanel, Saint Martin Du Fresne FR
Patent application number | Description | Published |
---|---|---|
20110020218 | NOVEL ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER - The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. | 01-27-2011 |
20110287451 | NOVEL ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER - The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. | 11-24-2011 |
20130031647 | HUMANIZED ANTI CXCR4 ANTIBODIES FOR THE TREATMENT OF CANCER - The present invention relates to a novel isolated humanized antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to hz515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered. | 01-31-2013 |
20140050661 | NOVEL ANTI-CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER - The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. | 02-20-2014 |
Véronique Grenier-Caussanel, Saint Martin Du Fresne FR
Patent application number | Description | Published |
---|---|---|
20110020218 | NOVEL ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER - The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. | 01-27-2011 |
20110294156 | NOVEL ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER - The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. | 12-01-2011 |
20130031647 | HUMANIZED ANTI CXCR4 ANTIBODIES FOR THE TREATMENT OF CANCER - The present invention relates to a novel isolated humanized antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to hz515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered. | 01-31-2013 |
Véronique Guyot-Ferreol, Paris FR
Patent application number | Description | Published |
---|---|---|
20090104135 | Use of Mineral/Organic Composite Material in the Form of an Ultraviolet Radiation Protective Agent - The invention relates to the use of composite material which comprises nanoparticles of a least one metal derivative and at least one organic sunscreen agent which is chemically bound with said particles in a covalent manner in the form of an ultraviolet radiation protective agent containing the inventive composite material. Cosmetic ultraviolet radiation protective compositions comprises said mixture are also disclosed. | 04-23-2009 |
20100291166 | USE OF NITROGEN-DOPED TITANIUM OXIDE NANOPARTICLES AS AGENTS FOR PROTECTING AGAINST ULTRAVIOLET RADIATION - A nanometric material includes nitrogen-doped titanium oxides, which is obtained by injection of a titanium oxide precursor in the liquid or gaseous form and of a gaseous nitrogenous compound into a laser pyrolysis reactor. The material is used as cosmetic agent for protecting against ultraviolet radiation, thereby improving protection against UV radiation and in particular against UV-A radiation. | 11-18-2010 |
Véronique Guyot-Ferreol, Paris FR
Patent application number | Description | Published |
---|---|---|
20100291166 | USE OF NITROGEN-DOPED TITANIUM OXIDE NANOPARTICLES AS AGENTS FOR PROTECTING AGAINST ULTRAVIOLET RADIATION - A nanometric material includes nitrogen-doped titanium oxides, which is obtained by injection of a titanium oxide precursor in the liquid or gaseous form and of a gaseous nitrogenous compound into a laser pyrolysis reactor. The material is used as cosmetic agent for protecting against ultraviolet radiation, thereby improving protection against UV radiation and in particular against UV-A radiation. | 11-18-2010 |
Véronique Hall-Goulle, Dornach CH
Patent application number | Description | Published |
---|---|---|
20080206658 | Compositions Containing Anthraquinone Dyes - A composition composition containing (A) an alkali-soluble binder and (B) an anthraquinone dye of formula (I) wherein R | 08-28-2008 |
20100021831 | TRANSPARENT COLOURANTS AND COLOURANT COMPOSITIONS, AND THEIR USE - The invention relates to a colourant composition comprising in a weight ratio of from 99:1 to 10:90, preferably a weight ratio of from 95:5 to 30:70, particularly preferred a weight ratio of from 95:5 to 50:50, a pigment of average particle size from 10 to 200 nm and a 1- or 2-phenylthio-substituted anthraquinones of greenish-yellow colour hue, lacking electron-rich N | 01-28-2010 |
20100186891 | NIR-INERT SUBSTRATES COMPRISING BIS-OXODIHYDROINDOLYLEN-BENZODIFURANONES - A method for producing infra-red inert substrates, including moulded polymeric articles, films, fibers and coatings and other organic and inorganic materials, by incorporating into the substrate or onto the surface of the substrate an effective amount of a dispersed bis-oxodihydroindolylen-benzodifuranone colourant. The thus obtained, also claimed substrates so produced are reflective and transparent to much of the near infra red radiation not reflected. There are multiple applications for cases of devices comprising electronic components, outdoor construction elements, outdoor furniture, automotive, marine or aerospace parts, laminates, artificial leather or textile materials, as well as in polychrome printing processes and optical fibers. The thus obtained substrates can also be subjected to laser welding. New bis-oxo-dihydroindolylen-benzodifuranone compounds are also claimed. | 07-29-2010 |
20100227199 | Blue Colour Filters with Enhanced Contrast - The invention relates to a process for enhancing the contrast of colour filters comprising α copper phthalocyanine or ε copper phthalocyanine, wherein a 1,4-diamino-anthraquinone dye or 1,9-annellated derivative thereof, of which the most bathochromic solution absorption peak in the visible spectrum is at from 575 to 615 nm, preferably at from 585 to 605 nm (as compared with around 630 nm for usual 1,4-diamino-anthraquinone dyes or 1,9-annellated derivatives thereof) is used in combination with α copper phthalocyanine or ε copper phthalocyanine. Also claimed are colour filters comprising such 1,4-diamino-anthraquinone dyes or 1,9-annellated derivatives thereof, as well as a novel compound of Formula (II), wherein R | 09-09-2010 |
20110112234 | PIGMENT MIXTURES - The present invention relates to novel pigment mixtures, comprising two different components A and B, wherein component A is a graphite in the form of platelets (graphite nanoplatelets), which have an average particle size of below 50 microns and a thickness below 100 nm, and component B is an organic, or inorganic pigment. The use of graphite nanoplatelets in a pigment mixture with organic and/or inorganic pigments, especially effect pigments (component B), allows the preparation of metallic like colorations with a maximal opacity (background substrate disappears totally) while keeping a good rheological behavior (low concentration use). | 05-12-2011 |
Véronique Hall-Goulle, Dornach CH
Patent application number | Description | Published |
---|---|---|
20100021831 | TRANSPARENT COLOURANTS AND COLOURANT COMPOSITIONS, AND THEIR USE - The invention relates to a colourant composition comprising in a weight ratio of from 99:1 to 10:90, preferably a weight ratio of from 95:5 to 30:70, particularly preferred a weight ratio of from 95:5 to 50:50, a pigment of average particle size from 10 to 200 nm and a 1- or 2-phenylthio-substituted anthraquinones of greenish-yellow colour hue, lacking electron-rich N | 01-28-2010 |
20100186891 | NIR-INERT SUBSTRATES COMPRISING BIS-OXODIHYDROINDOLYLEN-BENZODIFURANONES - A method for producing infra-red inert substrates, including moulded polymeric articles, films, fibers and coatings and other organic and inorganic materials, by incorporating into the substrate or onto the surface of the substrate an effective amount of a dispersed bis-oxodihydroindolylen-benzodifuranone colourant. The thus obtained, also claimed substrates so produced are reflective and transparent to much of the near infra red radiation not reflected. There are multiple applications for cases of devices comprising electronic components, outdoor construction elements, outdoor furniture, automotive, marine or aerospace parts, laminates, artificial leather or textile materials, as well as in polychrome printing processes and optical fibers. The thus obtained substrates can also be subjected to laser welding. New bis-oxo-dihydroindolylen-benzodifuranone compounds are also claimed. | 07-29-2010 |
20100227199 | Blue Colour Filters with Enhanced Contrast - The invention relates to a process for enhancing the contrast of colour filters comprising α copper phthalocyanine or ε copper phthalocyanine, wherein a 1,4-diamino-anthraquinone dye or 1,9-annellated derivative thereof, of which the most bathochromic solution absorption peak in the visible spectrum is at from 575 to 615 nm, preferably at from 585 to 605 nm (as compared with around 630 nm for usual 1,4-diamino-anthraquinone dyes or 1,9-annellated derivatives thereof) is used in combination with α copper phthalocyanine or ε copper phthalocyanine. Also claimed are colour filters comprising such 1,4-diamino-anthraquinone dyes or 1,9-annellated derivatives thereof, as well as a novel compound of Formula (II), wherein R | 09-09-2010 |
20120100395 | INDICATOR SYSTEM FOR MONITORING A STERILIZATION PROCESS - The present invention relates to a device for monitoring integral value of time, temperature comprising at least one layer of polymer comprising a latent pigment capable of undergoing at least one colour change, and an organic acid; or comprising one layer of polymer comprising a latent pigment capable of undergoing at least one colour change, and one layer of polymer comprising an organic acid, wherein said latent pigment is converted to its pigmentary form which causes said colour change. The device can be used for monitoring sterilization of medical and kitchen supplies, canned foods and doneness of microwave foods. | 04-26-2012 |
Véronique Hebmann, Saint Bauzille De Montmel FR
Patent application number | Description | Published |
---|---|---|
20110064793 | INHIBITORS OF HIV REPLICATION AND METHOD OF TREATMENT OF HIV INFECTIONS - The invention is drawn to a novel class of drugs directed against HIV, comprising a peptide or analog comprising a decapeptide, said decapeptide containing (from N-terminus to the C-terminus) a basic amino acid in position 1, an acidic amino acid in positions 2 and 5, and a tryptophan in positions 4, 7, and 8, and to a method of treatment of HIV infections, in particular multidrug-resistant HIV infections. | 03-17-2011 |
Véronique Hebmann, Saint Bauzille De Montmel FR
Patent application number | Description | Published |
---|---|---|
20110064793 | INHIBITORS OF HIV REPLICATION AND METHOD OF TREATMENT OF HIV INFECTIONS - The invention is drawn to a novel class of drugs directed against HIV, comprising a peptide or analog comprising a decapeptide, said decapeptide containing (from N-terminus to the C-terminus) a basic amino acid in position 1, an acidic amino acid in positions 2 and 5, and a tryptophan in positions 4, 7, and 8, and to a method of treatment of HIV infections, in particular multidrug-resistant HIV infections. | 03-17-2011 |
Véronique Laretta-Garde, L'Isle D'Adam FR
Patent application number | Description | Published |
---|---|---|
20100330157 | BIOMATERIAL FOR THE CONTROLLED DELIVERY OF INGREDIENTS - The disclosure relates to a biomaterial that comprises an aqueous phase, polymer network, a second polymer included in said disclosure invention more particularly relates to a biomaterial including an aqueous phase and a first polymer network made of a first proteic or saccharidic polymer or a mixture of first proteic and saccharidic polymers, wherein the first polymer network and the aqueous phase define a first gel (A), the biomaterial including: a second proteic or saccharidic polymer or a mixture of the second proteic and saccharidic polymers, either in solution in the aqueous phase of the gel (A) or in the form of a gel (B), and a first enzyme for degrading said second polymer or second polymer network. The disclosure also relates to a method for making biomaterials, and to the uses of the biomaterial particularly for releasing active substances, and to a device for the controlled release of active substances that include the biomaterial. The disclosure can particularly be used in the field of cosmetics and pharmaceuticals. | 12-30-2010 |
Véronique Laretta-Garde, L'Isle D'Adam FR
Patent application number | Description | Published |
---|---|---|
20100330157 | BIOMATERIAL FOR THE CONTROLLED DELIVERY OF INGREDIENTS - The disclosure relates to a biomaterial that comprises an aqueous phase, polymer network, a second polymer included in said disclosure invention more particularly relates to a biomaterial including an aqueous phase and a first polymer network made of a first proteic or saccharidic polymer or a mixture of first proteic and saccharidic polymers, wherein the first polymer network and the aqueous phase define a first gel (A), the biomaterial including: a second proteic or saccharidic polymer or a mixture of the second proteic and saccharidic polymers, either in solution in the aqueous phase of the gel (A) or in the form of a gel (B), and a first enzyme for degrading said second polymer or second polymer network. The disclosure also relates to a method for making biomaterials, and to the uses of the biomaterial particularly for releasing active substances, and to a device for the controlled release of active substances that include the biomaterial. The disclosure can particularly be used in the field of cosmetics and pharmaceuticals. | 12-30-2010 |
Véronique Le Sant, Le Mesnil Saint Denis FR
Patent application number | Description | Published |
---|---|---|
20130215927 | DEVICE FOR MEASURING A HEAT FLUX - The invention relates to a device for measuring a heat flux, comprising a thermopile formed of a plurality of thermojunctions of distributed type. The device is formed of a first and a second ceramic substrate (Ce | 08-22-2013 |
Véronique Maquet, Berloz BE
Patent application number | Description | Published |
---|---|---|
20100003292 | FINE-GRANULOMETRY FUNGAL EXTRACT CHITINE-GLUCANE - The present invention relates to a chitin-glucan copolymer in the form of micrometric particles. | 01-07-2010 |
20130156836 | Chitosan Bornet - The invention relates to a chitosan as a micronized powder, to its use for controlling certain yeasts, such as | 06-20-2013 |
Véronique Migonney, Eaubonne FR
Patent application number | Description | Published |
---|---|---|
20090318622 | Method for Grafting Bioactive Polymers on Prosthetic Materials - The invention concerns methods for grafting bioactive polymers on a prosthetic material, the materials obtainable by said method and applications thereof. More specifically, the invention concerns a method for directly grafting polymers on the surface of prosthetic materials. | 12-24-2009 |
Véronique Migonney, Eaubonne FR
Patent application number | Description | Published |
---|---|---|
20090318622 | Method for Grafting Bioactive Polymers on Prosthetic Materials - The invention concerns methods for grafting bioactive polymers on a prosthetic material, the materials obtainable by said method and applications thereof. More specifically, the invention concerns a method for directly grafting polymers on the surface of prosthetic materials. | 12-24-2009 |
Véronique Monjardet, Paris FR
Patent application number | Description | Published |
---|---|---|
20100015056 | Uranium-chelating peptides and uses thereof - The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence. | 01-21-2010 |
20110093964 | URANIUM-CHELATING PEPTIDES AND USES THEREOF - The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence. | 04-21-2011 |
Véronique Monjardet, Paris FR
Patent application number | Description | Published |
---|---|---|
20100015056 | Uranium-chelating peptides and uses thereof - The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence. | 01-21-2010 |
20110093964 | URANIUM-CHELATING PEPTIDES AND USES THEREOF - The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence. | 04-21-2011 |
Véronique Morisson-Iveson, Amersham GB
Patent application number | Description | Published |
---|---|---|
20120034165 | IMAGING THE CENTRAL NERVOUS SYSTEM WITH PURINERGIC P2X7 RECEPTOR BINDING AGENTS - The present invention provides novel compounds which may be used as in vivo imaging agents. The compounds of the invention are useful in a method to image the expression of P2X7 receptors in a subject, as a means to facilitate the diagnosis of a range of disease states. | 02-09-2012 |
Véronique Nery, Boussens CH
Patent application number | Description | Published |
---|---|---|
20130126438 | INSTALLATION AND PROCESS FOR RECYCLING WIPING SOLUTION OF ONE OR MORE INTAGLIO PRINTING PRESSES - There is described an installation ( | 05-23-2013 |
Véronique Orian-Rousseau, Rittershofen FR
Patent application number | Description | Published |
---|---|---|
20100305026 | CD44V6 peptides as inhibitors of bacterial infections - The present invention relates to the use of peptide compounds for the prevention and/or treatment of a bacterial infection. | 12-02-2010 |
20130072423 | CD44V6 PEPTIDES AS INHIBITORS OF BACTERIAL INFECTIONS - The present invention relates to the use of peptide compounds for the prevention and/or treatment of a bacterial infection. | 03-21-2013 |
20130109632 | USE OF VEGFR-2 IN THE TREATMENT OF OPHTHALMIC DISEASES | 05-02-2013 |
Véronique Orian-Rousseau, Rittershofen FR
Patent application number | Description | Published |
---|---|---|
20100305026 | CD44V6 peptides as inhibitors of bacterial infections - The present invention relates to the use of peptide compounds for the prevention and/or treatment of a bacterial infection. | 12-02-2010 |
20120115794 | USE OF CD44V6 IN THE TREATMENT OF OPHTHALMIC DISEASES - The present invention relates to the use of peptide compounds for the prevention and/or treatment of ophthalmic diseases. In particular, the present invention relates to a peptide compound comprising an amino acid sequence displayed by amino acids 7 to 11 of SEQ ID NO: 2 (KEQWFGNRWHEGYR) or of SEQ ID NO: 1 (KEKWFENEWQGKNP), or a functionally active derivative thereof, or a pharmaceutically acceptable salt thereof, for use in the prevention and/or treatmend of an ophthalmic disease in an individual. While SEQ ID NO: 2 is a part of the human CD44v6, SEQ ID NO: 1 is a part of the rat CD44v6. | 05-10-2012 |
Véronique Pauchon, Venejan FR
Patent application number | Description | Published |
---|---|---|
20130061780 | METHOD FOR PREPARING A COMPOSITE MATERIAL FROM WASTE AND RESULTING MATERIAL - A method for preparing a composite material from a waste appearing as sludge is provided. The method comprises a step consisting in putting said waste appearing as sludge in contact with a dry cement mixture. Also provided are the thereby obtained composite material and the use of such a method for treating and/or inertizing wastes and notably industrial and/or radioactive wastes. | 03-14-2013 |
Véronique Pêtre, Ceroux-Mousty BE
Patent application number | Description | Published |
---|---|---|
20130089639 | Low Glycaemic Index Baked Product Comprising High Levels of Fibre, Proteins and Inclusions - The present invention is directed to a bread product which is particularly adapted for breakfast, and which is characterized by high satietogenic and nutritional properties, and its convenience of use. Said bread product comprises 8-25 wt % of proteins, more than 6 wt % of fibres and 18-35 wt % of inclusions having an average size of at least 2 mm. | 04-11-2013 |
Véronique Poulain, Mons BE
Patent application number | Description | Published |
---|---|---|
20110027587 | Stable Thermistor - A thermistor based on a composition having the general formula (I): Re | 02-03-2011 |
Véronique Poulain, Mons BE
Patent application number | Description | Published |
---|---|---|
20110027587 | Stable Thermistor - A thermistor based on a composition having the general formula (I): Re | 02-03-2011 |
Véronique Preat, Kraainem BE
Patent application number | Description | Published |
---|---|---|
20110112115 | POLYMERIC MICROEMULSIONS - The invention provides novel self-emulsifying diblock copolymers and novel self-emulsifying compositions comprising an active ingredient and a diblock copolymer characterized in that the diblock copolymer is liquid at a temperature below 50° C. and the composition is non-aqueous and liquid at a temperature below 50° C. | 05-12-2011 |
20150086504 | POLYMERIC MICROEMULSIONS - The invention provides novel self-emulsifying diblock copolymers and novel self-emulsifying compositions comprising an active ingredient and a diblock copolymer characterized in that the diblock copolymer is liquid at a temperature below 50° C. and the composition is non-aqueous and liquid at a temperature below 50° C. | 03-26-2015 |
Véronique Preat, Kraainem BE
Patent application number | Description | Published |
---|---|---|
20110112115 | POLYMERIC MICROEMULSIONS - The invention provides novel self-emulsifying diblock copolymers and novel self-emulsifying compositions comprising an active ingredient and a diblock copolymer characterized in that the diblock copolymer is liquid at a temperature below 50° C. and the composition is non-aqueous and liquid at a temperature below 50° C. | 05-12-2011 |
Véronique Rebuffel, Corenc FR
Patent application number | Description | Published |
---|---|---|
20110204245 | PHOTONIC RADIATION DETECTION DEVICE, AND METHODS FOR DIMENSIONING AND OPERATING SUCH DEVICE - A photonic radiation detection device includes a collimator, a detector, means for localization in the detection plane defining on the one hand the partitioning of the detection plane in physical or virtual pixels of transversal dimensions smaller than those of the collimator channels, and associating on the other hand one of said pixels to each photon interaction. The detection device has at least in one previously selected acquisition configuration, a degree of pixelation in the detection plane greater than 1 and a collimator-detector distance (c) greater than one tenth of the septal height (h) of the collimator. A method for dimensioning such a device includes, for at least one given spatial frequency, calculating and comparing merit indicator values for different acquisition configurations of a structural model of the detection device. | 08-25-2011 |
20110260072 | Gamma-Camera Utilizing the Interaction Depth in a Detector - A method for underwater packaging of radioactive materials includes creating a vacuum in a cavity of a cleaning device to automatically cause a portion of the cleaning device to move upward to actuate the cleaning device from an open position to a closed position; mounting the cleaning device inside a safe containment area of a transportation and/or storage device; placing the transportation and/or storage device in a pool after filling the safe containment area with water; loading a radioactive material into the safe containment area; closing the transportation and/or storage device using at least one cover; extracting the transportation and/or storage device from the pool; draining the water inside the safe containment area; and creating a pressure differential in the safe containment area to dry the safe containment area, wherein the pressure differential causes the cleaning device to automatically actuate from the closed position to the open position. | 10-27-2011 |
Véronique Rosilio, Paris FR
Patent application number | Description | Published |
---|---|---|
20100160249 | NANOPARTICLE DERIVATIVES OF GEMCITABINE - The use of squalenic acid or a derivative thereof in formulating at least one polar active principle with a molecular weight of 100 Da or more, in the form of nanoparticles, and pharmaceutical compositions thereof. | 06-24-2010 |
Véronique Rosilio, Paris FR
Patent application number | Description | Published |
---|---|---|
20090130214 | Gemcitabine derivatives nanoparticles - The invention concerns a 2′,2′-difluoro-2′-deoxycytidine derivative of general formula (I), wherein: R | 05-21-2009 |
20100160249 | NANOPARTICLE DERIVATIVES OF GEMCITABINE - The use of squalenic acid or a derivative thereof in formulating at least one polar active principle with a molecular weight of 100 Da or more, in the form of nanoparticles, and pharmaceutical compositions thereof. | 06-24-2010 |
Véronique Rossow, Arcachon FR
Patent application number | Description | Published |
---|---|---|
20100080833 | STABLE, CONCENTRATED AND DILUTE, OIL-IN-WATER EMULSIONS, THEIR PROCESSES OF PREPARATION, AND FORMULATION PROCESS EMPLOYING THESE EMULSIONS - A stable oil-in-water emulsion, a process for the preparing such emulsion, and a formulation process employing the emulsion. The stable oil-in-water emulsion is obtained from an air-in-water preemulsion to which a simple or complex fatty substance is added by moderate mixing, preferably without exerting a shear force. The air-in-water preemulsion includes a surfactant, preferably a nonionic surfactant, a co surfactant chosen from hydrophilic compounds, preferably having at least one hydroxyl group, which are chosen in particular from the family of the polyols, and an aqueous phase. The ratios of these three components of the preemulsion are chosen within the region of ordered liquid crystal structure of the phase diagram of these three components and/or in ratios chosen so that the structure of the mixture of these three components, observed under a microscope in polarized light, exhibits birefringence characteristics. | 04-01-2010 |
Véronique Zennou, Paris FR
Patent application number | Description | Published |
---|---|---|
20110250650 | LENTIVIRAL VECTORS FOR THE PREPARATION OF IMMUNOTHERAPEUTICAL COMPOSITIONS - The invention relates to an immunogenic composition comprising a recombinant vector characterized in that it comprises a polynucleotide comprising the cis-acting central initiation region (cPPT) and the cis-acting termination region (CTS), these regions being of retroviral or retroviral-like origin, said vector comprising in addition a defined nucleotide sequence (transgene or sequence of interest) and regulatory signals of retrotranscription, expression and encapsidation of retroviral or retroviral-like origin, wherein the composition is capable of inducing or of stimulating a cell-mediated response for instance a CTL (Cytotoxic T Lymphocytes) response or a CD4 response, against one or several epitopes encoded by the transgene sequence present in the vector. | 10-13-2011 |
20120095083 | USE OF TRIPLEX STRUCTURE DNA IN TRANSFERRING NUCLEOTIDE SEQUENCES - A method to induce an immune response in a host in need thereof, comprises administering to the host, recombinant lentiviral vector particles comprising: | 04-19-2012 |
20120252113 | USE OF TRIPLEX STRUCTURE DNA IN TRANSFERRING NUCLEOTIDE SEQUENCES - The invention concerns a recombinant vector characterized in that it comprises a polynucleotide comprising a central initiation cis-active region (cPPT) and a termination cis-active region (CTS), the regions being of retroviral or retroviral-like origin, and the vector further comprising a predetermined nucleotide sequence (transgene or nucleotide sequence of interest) and retrotranscription regulating, expressing, and packaging signals of retroviral or retroviral-like origin. | 10-04-2012 |
20120252114 | USE OF TRIPLEX STRUCTURE DNA IN TRANSFERRING NUCLEOTIDE SEQUENCES - The invention concerns a recombinant vector characterized in that it comprises a polynucleotide comprising a central initiation cis-active region (cPPT) and a termination cis-active region (CTS), the regions being of retroviral or retroviral-like origin, and the vector further comprising a predetermined nucleotide sequence (transgene or nucleotide sequence of interest) and retrotranscription regulating, expressing, and packaging signals of retroviral or retroviral-like origin. | 10-04-2012 |